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ABSTRACT

The Pax7 gene is critical for specification of both neurons in the mid-brain and skeletal muscle
satellite cells. Several alternate transcripts are transcribed from the single gene. Previous studies have
shown that the resultant alternate Pax7 isoforms differ in the structure of their paired domain (a DNAbinding domain that influences target gene selection), yet the functional significance of each isoform
for specification of neurogenic and myogenic cell types remains unknown. Although previous studies
have identified the presence of multiple alternate Pax7 transcripts in both neurogenic and myogenic
cell lines, more research is necessary to understand the functional significance of the alternate Pax7
isoform that each transcript encodes. The aim of this research was to investigate DNA-binding
differences of each Pax7 isoform to reveal it's specific contribution to embryonic development. A
chromatin immunoprecipitation technique which purifies genomic fragments bound by individual
Pax7 isoforms was employed, for the purpose of determining DNA-binding differences.
Understanding the functional specificity of each Pax7 transcript i's important as these transcripts are
possible candidates for future stem cell/ gene therapy approaches aimed at developing novel
treatments for Neurodegenerative diseases and Duchene Muscular Dystrophy.
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CHAPTER ONE

INTRODUCTION

Chapter One: Introduction

Chapter 1

INTRODUCTION

1.1. The background to the study

The Pax7 gene is one of nine members of the Pax family of developmentally important
genes. During embryogenesis, Pax7 is predominantly expressed in the central nervous
system (CNS), condensing somites and migrating cranial and cephalic neural crest cells
(Kawakami et al., 1997; Stoykova and Gruss, 1994; Walther et al., 1991). These discrete
expression patterns signify the impm1ance of Pax7 for rieuronal differentiation, skeletal
muscle development, and the formation of craniofacial structures. Previous studies have
identified eight alternate Pax7 transcripts which encode eight alternate Pax7 isoforms.

Pax7 isoforms differ in their paired and transactivation domains, which are regions of the
Pax7 protein that are known to interact with deoxyribonucleic acids (DNA) and thus
influence target gene selection (paired domain), or form protein-protein interactions and
influence gene transactivation processes (transactivation domain) (Schafer et al., 1994).
The purpose of this study was to investigate whether Pax7 isoforms that have structurally
distinct paired domains bind to different target genes, and therefore possess functional
differences that will ultimately contribute in a unique manner to embryonic development.

1.2. Research question:

"DO PAX7 ISOFORMS SELECT DISTINCT TARGET GENES?''

1.3. The significance of the study

Previous knockout and transfection studies have shown that Pax7 is critical for skeletal
muscle satellite cell

specificatio~.

and neural sub-type specification in the mid-brain

(Thompson et al., 2006; Thomas et al., 2004; Matsunaga et al., 2001; Seale et al., 1999;
Jostes et al., 1990). However, the functional significance of each Pax7 isoform for cell
type specification is unknown. More research is necessary to discover DNA-binding

1
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differences of each Pax7 isoforin, as this will characterize the specific role of the
individual isoforms within a cell. Functionally-specific Pax7 isoforms, may provide novel
treatments for future stem cell/ gene therapy approaches to muscle and neural
degenerative diseases.

1.4. The purpose of the study

Structural differences in the DNA -binding domain exist between each Pax7 isoform
which may induce them to select specific target genes. From identification of target
specificity this study aimed to reveal the functional significance of each Pax7 isoform.
Moreover, this research sought to reveal whether Pax7 isoforms are functionally distinct;
are required to function in combination, or, are redundant for the overall function of the
Pax7 gene.

1.5. Aim

To identify Pax7 isoform-specific differences in target. gene selection, so as to
characterize each Pax7 isoforms' specific role during embryonic development.

1.6. Hypothesis

· The DNA-binding domain differences of each Pax7 ·isoform play a distinct role in
binding to specific target genes, and result in different target gene selection.

2
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LITERATURE REVIEW

Chapter 2

2.1.

GENE TRANSCRIPTION

Gene transcription is an elaborate molecular process that occurs in the nuclei of cells
involving the separation of the DNA double helix and transcription of one strand by a
ribonucleic acid (RNA) polymerase II enzyme (reviewed in Macfarlane, 2000). This
enzyme generates a primary RNA transcript or precursor messenger RNA (pre-mRNA)
molecule (Rosenthal, 1994) that is complementary to the template DNA coding strand
(Figure 2.1). The pre-mRNA molecule is then spliced and modified into mature mRNA,
which migrates from the nucleus to the cytoplasm of the cell (Zawel and Reinberg, 1993).
Gene transcription is a critical process and is the initial step in gene expression,

a

dynamic process that adapts to developmental and environmental cues (Reid et al., 2005).
The transcriptional event is activated and regulated by interactions between multiple,
highly specialized nuclear proteins called transcription factors (Lee and Young, 2000).

Figure 2.1. The transcription process: The RNA polymerase enzyme is a complex of
many proteins. This complex moves in a 3'-5' direction along the DNA strand,
synthesising RNA in a 5'-3' direction (Lodish et al., 2000; Alberts et al., 1998; Rosenthal,
1994; Singer and Berg, 1991). RNA synthesis produces a precursor messenger RNA (prernRNA) transcript that is complementary to the template DNA strand. The DNA rewinds
into the double helix behind the polymerase enzyme (Friedberg et al., 2002; Friedberg et
al., 2000).

3
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The binding of the polymerase enzyme to the promoter region depends on the presence of
bound regulatory transcription factor proteins that guide the polymerase machinery to the
transcription start site (Losick and Chanberline, 1976) (Figure 2.2.).

Promot r
I

Figure 2.2. Transcription factors binding to the promoter: Transcription factors bind
to the promoter site, generally located upstream at the 5' end of the gene, facilitating the
docking of RNA polymerase to the promoter start site and the activation of RNA
synthesis (Lodish et al., 2000; Alberts et al., 1998; Rosenthal, 1994; Singer and Berg,
1991).
2.1.1. The structure of the promoter
. The promoter region of a gene may contain a motif known as a TAT A box, which is a
short sequence of DNA (TATAAA or TATA) situated approximately 25 base pairs (bp)
upstream from the transcription start site (Butler and Kadonga, 2002) (Figure 2.3.) which
TATA-binding transcription factor proteins recognize and bind to to initiate transcription;
Other promoter elements also exist in genes of eukaryotes, and include GC boxes and
CCAAT boxes (Muller et al., 1988) (Figure 2.3.). The promoter may also be composed of
additional DNA elements that control the rate of transcription, known as enhancers and
silencers commonly situated upstream of the transcription start site (reviewed iri
Macfarlane, 2000).

4
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Proximal
control elements

Core
promoter

Start of transcription
GCbox

CAATbox

GGGCGG

GCCCAATCT

TATA box

Figure 2.3. The structure of a promoter region: The TATA box is commonly located
approximately 25bp upstream of the transcription start site. The GC and CCAA T box are
promoter elements often situated upstream of the TATA box and either enhance or
repress gene tr~nscription (Muller et al., 1988).

2.1.2. Transcription factors

Transcription factor proteins are located in the nucleus and interact with promoter sites
of genes to enhance or repress their rate of transcription, often switching on or off the
genes they control (reviewed in Macfarlane, 2000). Most transcription factors consist of
at least two functional domains, a DNA-binding domain which binds to promoter or
enhancer regions, and a transactivation domain that communicates via protein-protein
interactions with other transcription factors/cofactors or RNA polymerase (Butler and
Kadonga, 2002; Lee and Young, 2000). Certain transcription factors interact with DNA
by bending and looping it in a three dimensional orientation thus influencing the rate of
transcription (Brenner, 1961) (Figure 2.4.). Overall, the interactions between different
transcription factors, their target gene promoter sequences and RNA polymerase, form
the molecular basis of transcriptional control.

2.1.3. Enhancers

Enhancer regions are short sequences of DNA, which, when bound by their cognate
transcription factors, increase the rate of gene transcription (Muller et al., 1988) (Figure
2.4.). Silencer sequences are cis-regulatory elements that inhibit the transcription of a
gene (Muller et al., 1988). Repressor proteins bind to silencer regions to reduce the rate
of transcription. Characterized "enhancers" may behave as "silencers" under different
specific conditions (Kuras et al., 2003).
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en

RNA transcript

pranoter

Figure 2.4. The function of the enhancer sequence: The enhancer region may be
located upstream of the TATA box/promoter at the 5 1 end of the gene. Specific
transcription factors, coactivators and activator elements interact with either the promoter
or enhancer regions to loop and bend the intervening DNA, increasing the rate of gene
transcription (Muller et al., 1988).
2.1.4. RNA processing

The RNA transcripts produced from most eukaryotic protein-coding genes are further
processed to mature mRNA in the nuclei of cells (Janson, 2001). The modification of the
pre-mRNA begins with the addition of a specialized nucleotide (7-methylguanosine
1

triphosphate) at the 5 end of the primary transcript; this initial process is called capping
(Bannerjee, 1980) (Figure 2.5.). Capping is necessary to protect the RNA transcript
1

against nuclease degradation at the 5 end of the molecule. Polyadenylation then occurs
1

with the addition of adenyl ate adenosine monophosphate (AMP) residues at the 3 end of
the mRNA, forming a poly(A) tail (Figure 2.5.). The poly(A) tail, is necessary for
protection against enzymatic degradation (Jackson and Standart, 1990; Darnell, 1971).
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Figure 2.5. Modification of the pre-mRNA transcript by capping and
polyadenylation: The modification of pre-mRNA begins with the addition of a
specialized nucleotide linkage (7-methylguanosine triphosphate) at the 5' end of the
molecule in a process called capping. The capping process is then followed by the
addition of adenylate (AMP) residues at the 3' end of the pre-mRNA molecule, forming a
poly(A) tail in a process called polyadenylation (Jackson and Standart, 1990; Bannerjee,
1980; Darnell, 1971 ).
2.1.5. RNA splicing

. Splicing of pre-mRNA involves splicing intronic RNA segments out of the pre-mRNA
transcript, while the remaining exonic RNA segments are joined end-to-end, generating a
mature mRNA (reviewed in Matlin et al., 2005; Modrek and Lee, 2002; Burge et al.,
1999) (Figure 2.6.).
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r
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Exon

Exon 3
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Mature transcript:
Exon 1

Exon 2 Exon 3

Figure 2.6. RNA splicing: The primary transcript generated by gene transcription
contains coding segments (exons) separated by non-coding DNA sequences (introns).
During RNA splicing, introns are spliced out of the primary transcript and discarded. The
remaining exons join end-to-end to generate a mature mRNA transcript that is ready to
migrate from the nucleus into the cytoplasm of the cell to undergo translation into a
protein (Eperon et al., 1993).
A critical process in RNA splicing is the recognition of splice sites within introns
consisting of dinucleotides guanine and uracil (GU) and adenine and guanine (AG) at
exon/intron -boundaries (Figure 2.7.). Also the intronic branch site sequence is important
for correct splicing and includes an adenine nucleotide that is located towards the 3' end
of the intron (Norton, 1994) (Figure 2.7.). Splice sites are recognised by the spliceosome
complex. However some splice sites are degenerate (e.g. contain guanine and adenine
(GA) at the 5' end of the intron or thymine and guanine (TG) at the 3' end), making
spliceosome selection imperfect, resulting in alternative splice sites being selected, and
leading to the generation of alternative transcripts. Ultimately, the selection of different
splice sites generates mRNAs that differ in their exonic coding sequences therefore
producing distinct proteins.
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Figure 2.7. Exon/intron splice sites: RNA splicing of intronic sequences occurs when
dinucleotides GU are recognised at the 5' exon/intron splice site boundary. RNA splicing
of intronic sequences at the 3' splice site boundary occurs when dinucleotides AG are
recognised. The branch site indicated with an adenine (A) nucleotide acts as a branch site
for connecting both 5' and 3' ends generating a lariat shaped structure (Norton, 1994).
At the molecular level, RNA splicing begins with cleavage at the 5' splice site junction,
followed by the formation of a lariat shape structure and cleavage at the 3' splice site
junction (Figure 2.8.). This process releases the intronic RNA lariat and the remaining
exonic RNA segments are spliced together (Figure 2.8.). These reactions are orchestrated
by a large macromolecular enzyme complex called a spliceosome, composed of small
nuclear RNA and serine/arginine-rich (SR) proteins (reviewed in Garcia-Blanco, 2003)
(Figure 2.8.). This enzyme complex recognises the intronic splice sites and catalyses the
removal of introns (Garcia-Blanco et al., 2001; Burge et al., 1999).
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Figure 2.8. Spliceosomal removal of introns: The spliceosome interacts with premRNA transcripts to remove introns. The spliceosome is . composed of many small
nuclear RNA proteins (snRNPs) that interact with each other to splice out introns at the 5'
and 3' splice site junctions. Introns are removed by formation of a lariat structure; the
looped out sequence is discarded and the remaining exons splice together, forming
mature mRNA (Garcia-Blanco et al., 2001; Burge et al., 1999).
2.1.6. Alternative RNA splicing

Alternative RNA splicing is a mechanism that generates more than one mRNA
transcript from a single gene (Lynch and Conery, 2003). Alternate transcripts encode
multiple protein isoforms (reviewed in Matlin et al., 2005) (Figure 2.9.) all of which may
possess different functions. The number of alternatively spliced genes appears to increase
with the complexity of the organism; for example 10% of genes are alternatively spliced
in Caenorhabditis elegans, 25-40% in Drosophila and 60-80% in Homo Sapiens (Iida et
al., 2004; Kampa et al., 2004; Lee et al., 2004; Stole et al., 2004; Reboul et al., 2003;
Modrek and Lee, 2002; Beaudoing and Gautheret, 2001 ).
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Figure 2.9. Alternative RNA splicing generating multiple transcripts: Alternative
splicing is a process that generates more than one different mRNA transcript from the
same precursor messenger RNA (pre-mRNA). This process may form functionally
distinct proteins (Alberts et al., 1998; Stryer, 1995; Watson, 1987).

During alternative RNA splicing, it is also possible for exons and neighbouring introns to
be spliced out in a process known as exon skipping (McKeown, 1992). Exon skipping
also has the potential to produce different mRNA transcripts. For example, if a gene
possesses 9 exons, one mRNA product may include all exons, while another may skip
exon 5, resulting in production of variable mRNA transcripts. Alternatively multiple
exons together with their intervening introns can also be included in the final transcript.
Together these mechanisms of alternative RNA splicing produce multiple RNA
transcripts, which may or may not be functional.

2.2.

Pax GENES

2.2.1. General function and alternate splicing of the developmental Pax genes
Pax genes are a family of developmentally important genes encoding highly conserVed

transcription factors that are critical for the regulation of embryogenesis, a function first
revealed for the Drosophila melanogaster Pax gene prd (Bopp et al, 1986). Nine Pax
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genes (Paxl-9) have been identified in mammals (Jostes et al., 1990). These genes have
been classified into four well-defined subgroups I-IV based on similarities within their
protein structure and expression patterns during embryonic development; group I (Paxl
and 9), group II (Pax2, 5 and 8), group III (Pax3 and 7) and group IV (Pax4 and 6)
(Balczarek et al., 1997).

All Pax genes except Pax] and Pax9 are involved in central nervous system (CNS)
development as well as in specification of diverse organs during embryonic development.
Pax] and Pax9 play a critical role in the development of the vertebral column and in the

formation of endoderm embryonic layers (Holland et al., 1995). Pax] also plays a role in
thymus development (Wallin et al., 1996). Pax2 and Pax8 are involved in the
development of the brain, excretory system and the kidney (Dressler et al., 1990; Plachov
et al., 1990). Pax5 is known to play a vital role in the development of the brain and
immune system, specifically in the formation of B-lymphocytes (Adams et al., 1992).
Pax6 is well known as a master control gene in eye artd brain. development (Halder et al.,

1995) and together with Pax4 is involved in the development of the pancreas (Halder et
al., 1995; Quiring et al., 1994). Pax3 and Pax7 are involved in the specification of the
spinal cord, brain and muscular system (Jostes et al., 1990).

Diverse roles for each Pax gene may be due to the production of alternate transcripts or
multiple isoforms (Ziman et al., 1997). Interestingly, alternate transcripts of some Pax
genes exhibit diverse expression patterns indicating diverse roles for each transcript. For
example, six alternate Pax8 transcripts have been identified; and each transcript exhibits
discrete expression patterns during kidney and placental development (Poleev et al.,
1995; Kozmik et al., 1993). Furthermore, Pax2 alternate transcripts are known to exhibit
differential expression patterns during the formation of the eye, kidney and CNS
(Dressler and Douglass, 1992); two Pax6 transcripts display unique expression patterns in
both eye and brain development (Epstein et al., 1994) and alternate Pax3 transcripts
display distinct expression patterns in the developing neuromuscular system (Franz et al.,
1993; Epstein and Fischman, 1991).
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Previous studies have identified four alternate Pax7 transcripts Pax7a-d that possess
differential expression patterns in neurogenic and myogenic cell lineages (Ziman and
Kay, 1998; Ziman et al., 1997). Specifically, all four Pax7a-dtranscripts are expressed in
the myogenic lineage. However, only Pax7b and Pax7d transcripts are expressed in cells
of neurogenic lineage (Ziman and Kay, 1998). These in vitro studies suggest that Pax7
transcripts play a role in cell lineage determination, since transfection of a single Pax7b
transcript into cultured P 19 cells resulted in their differentiation into neural-like cells
(Ziman et al., 2001). Interestingly however, a single Pax7d transcript infected into
haematopoetic stem cells induced myogenic differentiation and upregulation of other
Pax7 alternate transcripts (Seale et al., 2004). The four transcripts of Pax7 have different

structural features that may alter the function of their paired DNA binding domain.

2.3.

Pax7 PROTEIN

2.3.1. Structural features ofPax7: DNA binding domains
The Pax7 protein contains several functional domains, a paired domain, an octapeptide,
a homeodomain and a transactivation domain (Figure 2.10.a.). The N-terminal paired
domain is a unique bipartite DNA binding structure containing approximately 128 amino
acids (Mansouri et al., 1994; Gruss and Walther, 1992). This structural feature comprises
two subdomains known as PAl (N-terminal) and RED (C-terminal), each containing three
alpha helices (Vogan and Gros, 1997; Vogan et al., 1996)(Figure 2.10.a.). The third helix
of each subdomain is primarily involved in sequence-specific DNA contacts (Ziman and
White, 2006). These two subdomains are separated by a linker region and allow the Pax7
protein to interact with DNA (Mansouri et al., 1994; Gruss and Walther, 1992) via
binding to downstream target genes (Figure 2.10.b.). Both PAl and RED subdomains are
capable of interacting simultaneously or independently with DNA (Jun and Desplan,
1996), as evidenced by a mutational study showing that mutations within the PAl
subdomain reduced PAl DNA-binding ability, but had no effect on the DNA-binding
ability of the RED subdomain (Xu et al., 1995).

The Pax7 protein contains a second DNA binding domain, the homeodomain, which
contains 60 amino acids and consists of three alpha helices (Scott et al., 1989; Frigerio et
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a!., 1986) (Figure 2.1 O.a.). The liomeodomain functions in combination with the paired
domain to influence target gene selection (Kozmik eta!., 1997; Underhill and Gros, 1997;
Vogan and Gros, 1997) (Figure 2.10.b.).

The octapeptide of Pax7 consists of eight amino acids, and is located between the paired
domain and homeodomain (Noll, 1993) (Figure 2.10.a.), and possesses a protein-protein
interaction function (Eberhard et al., 2000) (Figure 2.1 O.b.).

The Pax7 transactivation domain (Figure 2.1 O.a.), located at the C-terminus of the
protein, is rich in amino acids proline, threonine and serine; amino acids thought to be
sites of phosphorylation (Mikkola eta!., 1999). The transactivation domain may interact
with the general transcriptional machinery to regulate target genes to which the Pax7
protein is bound (Hadchouel eta!., 2003; Schafer eta!., 1994) (Figure 2.10.b.).

a

Paired Domain

Homeodomain

Transactivation

NPAl

RED

Octapeptide

Figure 2.10.a. Pax7 protein structure: The Pax7 protein consists of a paired domain,
comprising -two subdomains (PAl) and (RED) that are each composed of three alpha
helices (numbered), situated at the N-terminal of the Pax7 protein. The octapeptide is
located between the paired domain and homeodomain. The homeodomain contains three
alpha helices (numbered). The transactivation domain is located at the C-terminal end of
the Pax7 protein and is rich in amino acids serine, proline and threonine (Ziman and
White, 2006).

14

Chapter Two: Literature Review

Figure 2.10.b. Pax7 protein interacting with DNA:
The paired domain (PD), comprising PAl (N-terminal)
and
RED
(C-terminal)
subdomains
and
the
Homeodomain (HD) are the structures that allow the
Pax7 protein to interact with DNA of downstream target
genes. The homeodomain (HD) consists of three alpha
helices which interact with DNA and, together with the
paired domain, are assumed to influence target gene
selection. The Octapeptide (OP) domain is a proteinprotein interaction component within the Pax7 protein.
The transactivation domain (TD) is a protein-protein
interaction domain that allows the Pax7 protein to
activate transcription of downstream target genes by
interacting with the general transcription protein
machinery. All domains together control the regulation of
downstream target genes, switching them on or off
(Ziman and White, 2006; Du et al., 2005; Chi and
Epstein, 2002).

PO

TD

2.3.2. Differential splicing of the Pax7 paired box
As mentioned previously, the Pax7 gene encodes

sever~l

alternate transcripts with

differing sequences in the paired box gene region. Alternate Pax7 transcripts differ by
inclusion or exclusion of a trinucleotide (CAG which encodes a glutamine) and/or a
hexanucleotide (GTTTAG which encodes a glycine and leucine) at intron 2, exon 3
and/or intron 3, exon 4 boundaries, respectively (Ziman et al., 2001; Ziman and Kay,
1998; Vogan and Gros, 1997; Vogan et al., 1996) (Figure 2.11.). Alternate paired box
Pax7 transcripts that include or exclude a tri or hexanucleotide encode four alternate

Pax7 isoforms that differ by inclusion or exclusion of amino acids glutamine (Q), and/or
glycine and leucine (GL) within the PAl and RED subdomain regions of the paired
domain (Figure 2.11.). Isoforms are termed Pax7a (Q-, GL+), Pax7b (Q+,GL+), Pax7c
(Q-,GL-) and Pax7d (Q+,GL-) (Figure 2.11.).

Isoforms containing a single glutamine residue (Q+) within the paired domain are
hypothesized to use only the PAI subdomain of the paired domain to bind to DNA,
whereas the exclusion of a single glutamine residue (Q-) within the paired domain is
thought to result in utilization of both the PAI and RED subdomains of the paired domain
for DNA binding (Du et al., 2005; Vogan and Gros, 1997; Vogan et al., 1996). Thus,
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alternate Pax7 isoforms that differ in their paired domain structures may bind to different
downstream target genes, and possess differential functions.

Pa.irec::l c:letma.i.-.

N-

Pax7a

Pax7b

.Pax7c

Pax7d

(Q-, GL+)

(Q+,GL+)

(Q-, GL-)

(Q+,GL-)

Figure 2.11. Pax7 paired domain isoforms: The alternate Pax7 transcripts differ by
inclusion or exclusion of a trinucleotide (CAG) and/or a hexanucleotide (GTTTAG) at
exon/intron boundaries (Intron 2 I Exon 3 and Intron 3 I Exon 4, respectively) which
encode alternate Pax7 isoforms which differ by inclusion or exclusion of amino acids
glutamine (Q) and/or glycine and leucine (GL) within the paired domain producing four
alternate Pax7 isoforms Pax7a (Q-,GL+), Pax7b (Q+,GL+), Pax7c (Q-,GL-) and Pax7d
(Q+,GL-) (Ziman et al., 2001; Ziman and Kay, 1998; Vogan and Gros, 1997; Vogan et
al., 1996).
The Pax7 paired box transcripts Pax7a-d are tissue-specific and thought to be important
for cell differentiation along either myogenic and/or neurogenic cell lineages (Kay and
Ziman, 1999). Furthermore, encoded alternate Pax7 isoforms may differentially affect
transcription rate of target genes (i.e. either activation or repression) and thus have the
potential to possess distinctive functions in the developing embryo (Vogan et al., 1996).
This complexity of Pax7 isoform structure and DNA binding efficiency and specificity
may be responsible for the observed complexity of function. In this project we aim to
shed light on some of the diverse functions of the Pax7 protein.
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2.4.

Pax7 FUNCTION

2.4.1. Pax7 in central nervous system development
From expression patterns it is evident that the Pax7 protein plays a crucial role in the
development of the central nervous system. The Pax7 protein is expressed in the dorsal
neural tube prior to formation of the brain and spinal cord and has been observed in the
telencephalon and mesencephalon of mouse and chick brain (Nomura et al., 1998;
Kawakami et al., 1997; Stoykova and Gruss, 1994). Restricted expression has also been
observed in anterior and posterior regions of the caudal mesencephalon and rostral
hindbrain in zebrafish (Seo et al., 1998). Later in the development of mouse, chick and
zebrafish, Pax7 expression is confined to the dorsal midbrain, particularly the tectum/
superior colliculus and epiphysis (Picker et al., 1999; Kawakami et al., 1997; Krauss et
al., 1991). Other studies have shown that Pax7 is important for neural sub-type
specification in the chick and mouse mid-brain (Thomas et al., 2006; Thompson et al.,
2006; Thomas et al., 2004); Pax7 null mice lack superior colliculus neurons and have
severe facial deformities (Thompson et al., in preparation.) (Mansouri et al., 1994):
Moreover, Pax7 induces neural differentiation in vitro (Ziman et al., 2001).

2.4.2. Pax7 in muscle development
In situ hybridisation studies in mouse have shown that Pax7 is expressed in both

epaxial and hypaxial domains of condensing somites (Figure 2.12.), which form the
dorsal body wall, back muscles and specific precursor cells or satellite cells that migrate
to the limb buds (Lamey et al., 2004). These expression patterns define the Pax7 protein's
crucial role in skeletal muscle development. Satellite cells are important for repair and
regeneration of skeletal muscle tissue and growth by differentiation into myocytes. Seale
and colleagues (1999) have shown that Pax7 is critical for skeletal muscle satellite cell
specification. Significantly, Pax7 null mice completely lack skeletal muscle satellite cells
(muscle progenitor cells) hence muscle regeneration is severely impaired (Seale et al.,
1999).
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Figure 2.12. The Pax7 proteins crucial role in skeletal muscle development: In situ
hybridisation in chick showing Pax7 expression in the dorsal neural tube as well as in
both epaxial and hypaxial domains of condensing somites, forming the rudimentary
dorsal body wall and back muscles during development (Otto et al., 2006).
2.5.

DOWNSTREAM TARGET GENES

2.5.1. Target genes of the Pax7 protein
In order to identify the target genes bound by Pax7 and thus identify the gene pathways

regulated by Pax7 a chromatin immunoprecipitation (ChiP) technique (White and Ziman,
2006) was utilized. Using this technique several genomic fragments bound by the Pax7
protein in developing mouse embryos were isolated, allowing identification of a
definitive set of target genes bound by Pax7 in vivo. These target genes are
predominantly development genes involved in cellular proliferation and cell signalling
important for development (White and Ziman, 2006).

A cohort of these identified target genes have been chosen for further study in this project
based on their critical cellular and developmental functions associated with neurogenesis
and myogenesis. These genes are as follows:

The Pax7 target gene, CntfR (ciliary neurotrophic factor receptor), encodes a receptor for
the cytokine, Interleukin-6 (IL-6), known to play a critical role in both peripheral and
central nervous systems (Ip et al., 1993). CntfR also plays a functional role in muscle
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repair and regeneration; since application of CNTF to rejuvenating muscles in vivo
stimulates myotube formation (Marques and Neto, 1997).

The target gene, Eya4 (eyes absent 4 homologue) encodes a transcriptional regulatory
factor that has been shown to play a critical role during dorsal somite development in
early myogenesis (Borsani et al., 1999; Davis et al., 1999; Esteve and Bovolenta, 1999;
Relaix and Buckingham, 1999; Mishima and Tomarev, 1998; Xu et al., 1997; Williams
and Ordahl, 1994; Jostes et al., 1990). During mouse embryonic development, Eya4 is
also expressed in the craniofacial mesenchyme (Borsani et al., 1999). Interestingly, Eya4
expression in the somite and the dermomyotome as well as in cells migrating to the
developing limb buds strongly resembles Pax7 expression patterns during development
(Christ and Ordahl, 1995; Bober et al., 1994).

The Gbxl target gene (gastrulation brain homeobox 1) encodes a homeodomain
transcription factor that controls the development of neuronal. cell types in the developing
dorsal spinal cord and it's expression domain establishes the midbrain-hindbrain
boundary (Rhinn et al., 2004). Gbxl is also expressed later in the developing hindbrain,
in the ventral telencephalon, optic vesicles and spinal cord (Rhinn et al., 2004).

The Kcnk2 target gene (potassium channel K2) commonly known as TREKJ encodes a
potassium channel protein critical for the physiological properties and modulatory
potential ofneurons (Bockenhauer et al., 2001; Talley et al., 2001). The gene has shown
differential patterns in the CNS, being expressed in dorsal root ganglion and the superior
colliculus (Talley et al., 2001 ), the midbrain region specified by Pax7 (Thomas et al.,
2006; Thomas et al., 2004; Jostes et al., 1990).

The Rasa3 target gene (RAS p21 protein activator 3) is associated with cell signalling and
cellular transformation. It has previously been demonstrated that cyclin-dependent kinase
inhibitor 1A (p21) Ras protein plays a functional role in stimulating cell survival,
signalled by nerve growth factors in rat sympathetic neurons (Nobes et al., 1996).
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The Prrxl target gene (paired-related homeobox 1) is a paired-class homeobox gene that
is expressed in the craniofacial mesenchyme and limb buds. Prrxl mutants show skeletal
deficiencies in the skull, vertebral column and limbs (Mattin et al., 1995). Further
evidence has been obtained by gene targeting experiments demonstrating that the
homeobox gene Prrxl is critical for craniofacial and limb development as well as
vascular regulation (Chesterman et al., 2001).

The binding of alternate Pax7 isoforms individually to these previously identified target
genes formed the basis of the project.

2.6.

CHROMATIN IMMUNOPRECIPITATION

· Investigating protein-DNA interactions by identifying the target genes of transcription
factors is crucial for understanding the mechanisms of gene expression (reviewed in
Taverner et al., 2004). Chromatin immunoprecipita:tion (ChiP) is a new and valuable
methodology offering a snapshot of transcription factor bindil).g to DNA promoter sites in

vivo and has revolutionized our knowledge of gene transcription (Weinmann, 2004;
Weinmann and Farnham, 2002; Wells and Farnham, 2002; Kuo and Allis, 1999).

Before

ChiP

was

developed,

deoxyribonuclease

(DNase)

I

footprinting

and

Electrophoretic Mobility Shift Assays (EMSA) were employed to investigate proteinDNA interactions (Peng and Chen, 2005; Chen and Zack, 2000). DNase I footprinting
is/was used ·to investigate the binding of transcription factors to promoters or enhancer
sites over large regions of DNA (Peng and Chen, 2005; Chen and Zack, 2000). In this
technique approximately 200-400bp DNA fragments are labeled with radioisotopes and
digested with DNase I in the presence or absence of a protein. The region of DNA that is
bound by transcription factor proteins are protected from DNase I digestion, and are
identifiable as a gap in DNA sequence on a denaturing polyacrylamide DNA sequencing
gel (Peng and Chen, 2005; Manuel et al., 2002; Rmilet et al., 2002). In contrast, EMSA
is/was used to confirm the binding of specific transcription factors to short DNA
sequences or oligonucleotide (Peng and Chen, 2005; Chen and Zack, 2000). The binding
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is detected by high molecular weight band shifts in a nondenaturing polyacrylamide gel
(Peng and Chen, 2005; Chen and Zack, 2000; Chen et al., 1997).

Although both assays investigate protein-DNA binding in vitro they are unable to
adequately identify specific target genes of transcription factors (Peng and Chen,

2005)~

To overcome the limitations of these techniques, the chromatin immunoprecipitation
methodology was developed, specifically to study the binding of endogenous
transcription factors to the promoters of specific DNA sequences in vivo (Kirmizis and
Farnham, 2004; Wells and Farnham, 2002).

When using ChiP methodology, transcription factors associated with chromatin DNA at
any one time are cross-linked to the DNA by formaldehyde. This step is followed by
sonication to shear chromosomal DNA, the protein-DNA complexes are then
itnmunoprecipitated

using

an

Immunoprecipitated

protein-DNA

antibody
complexes

against
are

the

crosslinked

ext((nsively

washed,

protein;
eluted,

decrosslinked and the DNA is purified and analyzed for the presence or absence of
specific DNA sequences by polymerase chain reaction (PCR) for known DNA target
sequences utilizing gene-specific primers (Wells et al., 2002; Wells and Farnham, 2002)
(Figure 2.13.) or by cloning and sequencing to identity targets (White and Ziman, 2006).

The technique has been utilized in tissues from a variety of species, including mouse
embryos (White and Ziman, 2006), protozoa (Dedon et al., 1991a; Dedon et al., 1991b),
sea urchin embryos (Jasinskiene et al., 1995), and Drosophila (Orlando et al., 1997;
Orlando and Paro, 1993). Very few studies have utilized this technique in vitro (Agbottah
et al., 2006; Esumi et al., 2006; Gong et al., 2006; Valineva et al., 2006).
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Figure 2.13. Chromatin immunoprecipitation technique: The initial step of the
technique involves formaldehyde crosslinking of protein expressed in either cultured cells
or tissues to DNA. Protein-DNA complexes are then sonicated, immunoprecipitated with
an antibody against the protein of interest. The immunoprecipitated complex is washed,
eluted, decrosslinked and the DNA (target gene) purified and analyzed via PCR utilizing
gene-specifi_c primers for known DNA target sequences or by cloning for unknown
targets. A sample that is not subjected to immunoprecipitation (no antibody) acts as a
negative control (Peng and Chen, 2005).
2.7.

SUMMARY

Previous studies have identified eight structurally distinct Pax7 isoforms. This DNAbinding study, focuses on identification of DNA binding specificities of four of the Pax7
paired domain isoforms. These isoforms are Pax7a (Q-, GL+), Pax7b (Q+, GL+), Pax7c
(Q-, GL-) and Pax7d (Q+, GL-). Given that Pax7 isoforms differ in their paired domain
structure, it is probable that DNA-binding domain differences will result in selection of
specific downstream target genes. Previous studies have identified alternate Pax7
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transcripts present in both neurogenic and myogenic cell lines, however more research is
necessary to understand the functional significance of the encoded alternate Pax7
isoforms.

From identification of target specificity this study sought to reveal the functional
significance of each Pax7 isoform. This study therefore aimed to investigate DNAbinding differences utilizing the chromatin immunoprecipitation technique. It was felt
that by using ChiP, we would identify specific downstream target genes of each Pax7
isoform. We used a specific subset oftarget genes CntjR, Eya4, Gbxl, Rasa3, Kcnk2 and

Prrxl previously identified as Pax7 targets, and assessed binding of Pax7 isoforms to
these genes in a cell culture system. It was anticipated that these experiments would
provide new insights into the DNA-binding differences of each Pax7 isoform and thus
identify their roles during embryogenesis. Recent experiments have used specific Pax7
transcripts to induce neural and muscle cell differentiation from stem cells. The Pax7
transcripts are therefore candidates for advances in futur.e stem cell/ gene therapy
approaches aimed at developing novel treatments for Neurodegenerative diseases and
Duchene Muscular Dystrophy. It is important therefore to understand the pathways
regulated by each transcript.
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METHODS

Chapter 3

3.1.

Research Plan

The purpose of this study was to identify Pax7 isoform specific downstream target
genes, to provide insight into the functional significance of each isoform. To do this cells
were transfected with each Pax7 alternate transcript and then subjected to Chromatin
Immunoprecipitation (ChiP) (Figure 3.1.).

Alternate transcripts of Pax7 cloned into a V5.:.epitope tagged expressiOn vector

pcDNA3.1D/V5-His-TOPO were transfected into a mouse NIH3T3 fibroblast cell line.
Stably transfected cells were selected in geneticin antibiotic (G418) and assessed for
Pax7-vector expression by reverse transcriptase-polymerase chain reaction (RT-PCR)
and for translated protein by immunocytochemistry and western blot. Stably transfected
cells were treated with formaldehyde to crosslink the Pax7 protein to DNA, then proteinDNA complexes were extracted and sonicated. Individual Pax7 isoforms and bound DNA
were immunoprecipitated, and the purified genomic fragments were analysed by PCR
with primers selecting for known Pax7 target genes (White and Ziman, 2006).

Target genes that were analysed in this study were: CntfR (ciliary neurotrophic factor

receptor), Eya4 (eyes absent 4 homologue), Gbx1 (gastrulation brain homeobox 1),
Kcnk2 (potassium channel K2), Rasa3 (RAS p21 protein activator 3) and Prrx1 (pairedrelated homeobox 1).

Cells transfected with the pcDNA3.1D/V5-His-lacZ expression vector and untransfected
cells were included as controls. All transfection experiments and controls were performed
in triplicate. Experimental procedures were conducted utilizing NIH3T3 mouse
embryonic fibroblasts and P19 mouse embryonic carCinoma cells.
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1- Transfect transcriptcarrying epitope-tagged
vectors into cells
2- Link Pax7-isoform to
DNA (target gene) with
formaldehyde
6- Extract DNA

[([~

4- Sonicate Pax7isoform-DNA
complex

Figure 3.1. A schematic representation of the ChiP protocol: Pax7 transcripts cloned
into epitope-tagged expression vectors were stably transfected into a NIH3T3 mouse
fibroblast cell line [1]. The Pax7 protein was crosslinked to the DNA (downstream target
genes) with formaldehyde [2] followed by extraction [3] and sonication [4].
Immunoprecipitation of the Pax7 isoform using an antibody to the epitope [5] was then
followed by DNA extraction [6]. Finally DNA was analysed by PCR utilizing primers
specific for promoter fragments 'of selected target genes [7].
3.2.

VECTOR PREPARATION

3.2.1. Amplification of epitope-tagged expression vectors containing Pax7(a-d)
transcripts
Glycerol stocks of pcDNA3.1 D/V5-His vectors containing individual Pax7 transcripts
inserted in frame so as to produce a Pax7-V5His6 fusion protein (Figure 3.2.) were kindly
donated by Robert White. Clones were streaked on Luria-Bertani (LB) agar containing
lOOJ.lg/ml ampicillin and incubated overnight at 37°C. Individual colonies were randomly
picked and inoculated into 5ml ofLuria-Bertani (LB) (lOg/L NaCl, lOg/L tryptone, 5g/L
yeast) broth containing lOOJ.lg/ml of ampicillin. Cultures were grown overnight on a
rocking platform at 37°C. E. coli colonies containing control pcDNA3.1D/ V5-His-lacZ
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vector alone were also cultured (Figure 3.3.). A small quantity of each culture was
amplified by PCR (Section 3.2.4.) to validate the presence and correct orientation of
alternate Pax7 inserts in the pcDNA3.1DIV5-His-TOPO expression vector.

Pax7 transcript inserted
into vector

!

pcDNA3.ID/
~ VS-His- OPO
"t2.
~

~

5.5 kb

Figure 3.2. Pax7 alternate transcript inserted into the pcDNA3.1DIV5-His-TOPO
vector containing 3' VS and His6 sequences (Invitrogen).

pc0NATM3.1 0/
V5-His//acZ
8586 bp

Figure 3.3. pcDNA3.1DIV5-His-lacZ control vector (Invitrogen).
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3.2.2. Isolation of alternate Pax.7(a-d) vector constructs
Once the E. coli colonies were identified as having the correct Pax7 insert by PCR, they
were grown in 5ml LB medium containing lOOflg/ml of ampicillin. A miniprep plasmid
purification kit (Qiagen) was used to purify plasmid DNA from each E. coli culture as per
manufacturer's instructions.

Briefly, 5ml cultures were pelleted at 4500rpm for 1.5

minutes, resuspended in 250fll of resuspension Buffer (PI) (50mM Tris·Cl, pH 8.0; IO
mM ethylenediaminetetra-acetate (EDTA); IOO flg/ml ribonuclease (RNase) A), followed
by the addition of lysis Buffer (P2) (250f.!l) (200 mM Sodium hydroxide (NaOH), 1%
Sodium dodecyl sulfate (SDS). Neutralization Buffer (N3) (350f.!l) (3.0 M potassium
acetate (CH3COOK), pH 5.5) was added to each sample, mixed immediately and
samples were centrifuged at I3 OOOrpm for IO minutes. Supernatants were applied to
QIAprep Spin Columns and centrifuged at 13 OOOrpm for 30 seconds. Plasmid DNA was
then washed with phosphate binding buffer (PB) (500f.!l), and centrifuged at 13 OOOrprri
for 30 seconds, then DNA cleanup buffer (PE) (600f.!l), was added and the DNA
preparation was centrifuged at I3 OOOrpm for 30 seconds,

t~en

for 1 minute to remove

residual wash buffer. DNA was eluted by applying distilled deionised water (50f.!l) to the
column for I minute at room temperature, then centrifuged for I minute at 13 OOOrpm.

3.2.3. Agarose gel electrophoresis
Agarose gel electrophoresis was performed to assess the quantity and quality of
Pax7(a-d)-pcDNA3.1D/V5-His-TOPO vector DNA.

Isolated DNA (5f..ll) from plasmid preparations was diluted in 6x loading buffer (50mM
EDTA, 40%v/v glycerol, 0.24%w/v Bromophenol blue) applied to a I %w/v agarose gel
and electrophoresed in TAE buffer (40mM Tris-acetate pH 8, ImM EDTA) containing
5f.!g/ml ethidium bromide (Sigma) at a constant I 05V for I hour. Sizes of products were
estimated by comparison to a DNA size ladder (I· Kb Plus, Invitrogen). The gel was
viewed on a UV Biorad Gel Doc System and photographed.
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3.2.4. Polymerase Chain Reaction (PCR) of Pax7(a-d)-pcDNA3.1D/V5-His-TOPO
eDNA constructs
To confirm that alternate Pax7 transcripts were correctly incorporated into the vector in
the expected orientation PCR reactions were performed on Pax7a-d-vector constructs.
The forward primer (F4) 5'-CACCGACTCTGGATTCGTCTCCAGCGTG-3' was
utilized since the first four bases are vector specific (underlined bases) and the rest of the
primer spans the 5' untranslated region of Pax7. This primer was utilized in combination
with a reverse primer (BGH) 5' -TAGAAGGCACAGTCGAGG-3', that spans a region in
the vector that is 3' of the insert. PCR reactions were conducted utilizing an MJ Research
PTC-200 Peltier thermal cycler (Geneworks) with a heated lid.

PCR reactions (20J11) contained DNA template (lJ.ll/ml), primers (lJ.lM each),
deoxynucleotide triphosphate (dNTP) (200J1M each) (Finnzymes), PCR buffer (lx
Qiagen), Q solution (lx Qiagen), Taq DNA polymerase (2.5 Units (U), Qiagen). Optimal
cycling

conditions

utilising

the

forward .

primer

F4

5'-

CACCGACTCTGGATTCGTCTCCAGCGTG-3' in combination with the reverse primer
BGH

5'-TAGAAGGCACAGTCGAGG-3',

for

Pax7-pcDNA3.1D/V5-His-TOPO

complementary deoxyribonucleic acid (eDNA) constructs were as follows; an initial
denaturation step of 94 oc for 3 minutes, followed by 36 cycles of 94 oc for 30 seconds
(denaturation), 52°C for 2 minutes (annealing), 72°C for 30 seconds (extension) and
final extension at 72°C for 10 minutes.

A forward pnmer (T7)

5'-TAATACGACTCACTATAGGG-3' was utilized in

combination with the reverse primer (BGH) 5' -TAGAAGGCACAGTCGAGG-3', to
confirm the correct control vector sequence.

Optimal

cycling

conditions

utilizing

the

forward

primer

T7

5'-

TAATACGACTCACTATAGGG-3' in combination with the reverse primer BGH 5'TAGAAGGCACAGTCGAGG-3', for pcDNA3.1D/V5-His-lacZ vector alone were as
follows; an initial denaturation step of94°C for 3 minutes, followed by 36 cycles of94°C
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for 30 seconds (denaturation), S2°C for 2 minutes (annealing), 72°C for 30 seconds
(extension), then a final extension at 72°C for 10 minutes.

Agarose gel electrophoresis was performed to determine the size of PCR products for

Pax7(a-d)-pcDNA3.1DIV5-His-TOPO vector DNA. PCRproducts (5f!l) were analysed as
in Section 3.2.3.

3.2.5. Determination of DNA concentration
Purified plasmid DNA, was diluted 50 fold m distilled deionised water and the
concentration was measured using a biophotometer (eppendorf). Absorbance at 260nm
(A260) was measured in triplicate for each sample. The following formula were used to
calculate concentration:

[Double stranded DNA (dsDNA)]: 1 Az60 unit x 50= 50f!g/ml

3.3.

CELL CULTURE

3.3.1

Maintenance of NIH3T3 and P19 cells in culture

NIH3T3 mouse embryonic fibroblast cells (ATCC) at fifteenth passage (P 15 ) were
grown in 5ml Dulbecco's Modified Eagles Medium (DMEM) containing 10% Fetal
Bovine Serum (FBS) (Invitrogen) and 1% L-glutamine (Invitrogen) in 25cm2 cell culture
flasks (T25). Cells were incubated at 37°C in a 5% carbon dioxide (C02) atmosphere.
The medium was replaced every 48 hours until cells became 90-95% confluent.
Confluent cells were passaged by adding 2ml accutase (Sigma) to the flask to lift the
cells, the cells were transfered to a 15ml falcon tube and centrifuged at 500rpm for 5
minutes at room temperature. The supernatant was discarded, new medium (1ml) was
2

added and cells were resuspended and distributed into 25cm2 flasks or 1Ocm 6 well
culture plates at a concentration of 1x105cells/ml. Cells were grown to confluency, at
which time individual Pax7(a-d) transcripts were transfected into each 10cm2 well. Cells
not subjected to transfection were grown in 25cm2 cell culture flasks and subjected to
chromatin immunoprecipitation (ChiP) studies as input samples (untransfected, NIH3T3
chromatin samples not subjected to immunoprecipitation) (Section 3.5.4.). A P19 mouse
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embryonic clone (ATCC) P20 already transfected with the Pax7d transcript, and
untransfected P19 cells were also cultured in conditions as stated for NIH3T3 cells.

3.3.2. Transfection and selection of stable clones
Once cells were 90-95% confluent, DNA containing purified Pax7(a-d)-pcDNA3.1/V5His-TOPO eDNA constructs (4.0f.tg) or pcDNA3.1/V5-His-lacZ vector (control) were

transfected into NIH3T3 cells in 10cm2 culture wells, using lipofectamine 2000 reagent
(lOJll) (Invitrogen). Since the pcDNA3.1D/V5-His-TOPO vector contains a neomycin
resistant gene, constructs that had stably integrated into the NIH3T3 genome were
selectively grown in cell culture medium containing G418 antibiotic (Invitrogen).
Medium, containing 0.5mg/ml G418 was replaced every 72 hours for the next 21 days for
selection. Thereafter, medium containing 0.25mg/ml G418 was replaced every 72 hours
for 7 days to maintain selection.

After the 28-day selection period, NIH3T3 cells that were transfected with Pax7(a, b,

c

and d)-vector constructs were transferred into individual flasks (25cm2) and allowed to
propagate for subsequent use in expression and Chromatin Immunoprecipitation (ChiP)
studies.

3.3.3. Photography of cell culture
Alternate Pax7(a-d) clones resistant to G418 were viewed with a Leica microscope and
photographed using an Olympus Digital camera at 20x magnification.

3.4. EXPRESSION STUDIES TO CONFIRM TRANSFECTION OF Pax7
TRANSCRIPTS IN NIH3T3 CELLS
3.4.1

Western blot of transfected cells

3.4.1.1. Protein extraction
NIH3T3 cells transfected with Pax7(a-d)-pcDNA3.1DIV5-His-TOPO were washed
with 1ml phosphate buffered saline (PBS), scraped into individual eppendorf tubes, and
centrifuged at 1500rpm for 5 minutes. Cells were resuspended in 50Jll cell lysis buffer
(50mM Tris-HCL, pH 7.8, 150mM NaCl, 1% Nonidet P-40) containing lx proteinase
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inhibitor cocktail (Roche), briefly vortexed and incubated at room temperature for 15
minutes. Debris was then centrifuged at 10 OOOrpm for 10 minutes at 4°C, and
supernatants were collected and stored at -80°C.

3.4.1.2. Protein concentration determination

Celllysates were diluted (20 fold, 40 fold and 50 fold) in distilled deionised water and
protein concentration was measured using a biophotometer. Absorbance at 280nm (A 280)
was measured in triplicate for each sample. The following formulae were used to
calculate protein concentration:

[Protein mg/ml]: (1.55 x 1 A280 unit)- 0.76 x 1 A260 unit)

3.4.1.3.Western blot

Western Blot was employed to confirm the correct expression and translation of Pax7
isoforms. The presence of the individual Pax7(a-d)-vector proteins in transfected cells
were identified by either the Anti-V5 monoclonal antibody or the Pax7 monoclonal
antibody.

3.4.1.4. Polyacrylamide gel electrophoresis

A 8% separating acrylamide gel was prepared (Tris-HCl 1.5M pH 8.8, 8%
Acrylamide/Bis and 10% SDS) the gel was degassed for 10 minutes at room temperature,
followed by the addition of catalysts ammonium persulfate (10%) and 2x10-8M TEMED.
The gel was loaded into the gel apparatus and left to polymerize. The stacking gel was
prepared (Tris-HCl 0.5M pH 6.8, 4% Acrylamide/Bis and 10% SDS) degassed for 10
minutes at room temperature, followed by the addition of catalysts ammonium persulfate
(10%) and 4x10-8M Tetramethylethylenediamine (TEMED), loaded into the gel apparatus
on top of the stacking gel and left to polymerize.

Cell lysates were diluted in 2x SDS sample buffer (0.5M Tris-HCl, 10% Glycerol,
5x10-6M B-mercaptoethanol, O.OOIM SDS, 3x10-5M Bromophenol blue), vortexed and
boiled for 5 minutes at 100°C. The electrophoresis tank (Biorad) was filled with lx SDS
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running buffer (3.03g Tris, 14.4g Glycine, lg SDS). Protein samples were loaded onto
the gel (20fll) and the gel was run at constant 200V (Laemmli, 1970).

3.4.1.5. Transfer of proteins to nitrocellulose membrane
Proteins were transferred from the gel to a nitrocellulose membrane as follows: A
transfer sandwich was assembled under transfer buffer (0.02M Tris, 0.08M Glycine,
0.00 l M SDS, 20% methanol (MeOH) consisting · of l fibre sheet, 2 filter papers,
polyacrylamide gel electrophoresis (PAGE), nitrocellulose paper, another filter paper and
a final fibre sheet (Figure 3.4.). The sandwich was placed into the plastic transfer cassette
and into the transfer tank, and internal and external sections were filled with transfer
buffer (0.02M Tris, 0.08M Glycine, O.OOIM SDS, 20% MeOH) and run at a constant 20V
overnight at 4°C. After disassembly, the nitrocellulose membrane was cut for orientation
of protein samples and the ladder (Precision Plus standard protein ladder, BioRad)
marked on the membrane.

e
0.
~~

filter paper

~

0

gel

::::>

2.

membrane

iil
;:)
[~

filter paper

rD
~

(f)

'

Figure 3.4. Nitrocellulose membrane sandwich: The sandwich was assembled as
follows; l fibre sheet, 2 filter papers, PAGE gel, nitrocellulose paper, filter paper, fibre
sheet (Laemmli, 1970).
3.4.1.6.VS antibody membrane probing
. The nitrocellulose membrane was immersed

tn

blocking buffer containing 1x Tris

buffered saline (TBS) pH 7.4, Tween-20 (0.1 %) and dry non-fat skim milk (5%), for 2
hours on an orbital shaker at a constant medium rotation. Anti-V5 antibody (1200flg/ml)
(Invitrogen) was diluted 1:5000 in blocking buffer (lx Tris buffered saline with Tween20 (TBST), dry non-fat skim milk 2.5%). The Anti-V5 antibody was added to the

32

Chapter Three: Methods
nitrocellulose membrane and incubated for 2 hours at room temperature on an orbital
shaker at a constant slow rotation. The membrane was washed sixteen times in 1x Tris
buffered saline with Tween-20 (TBST) for 15 minutes on an orbital shaker at room
temperature.

IgG-linked to horseradish peroxidise diluted 1:2000 in 1x TBST, was applied to the
nitrocellulose membrane incubated for 1 hour at room temperature on an orbital shaker at
a constant slow rotation. The membrane was washed 8 times in 1x TBST for 15 minutes
on an orbital shaker at room temperature.

3.4.1.7. Visualization
Probed membranes were visualized by chemiluminesance utilizing the ECL Plus
Western Blot Detection Kit (Amersham). ECL kit detection reagents were equilibrated at
room temperature, and mixed together (solution A 98% solution B 2%) and added to the
nitrocellulose membrane, then incubated at room temperature for 5 minutes. The
nitrocellulose membrane was sandwiched between transparent overhead sheets and
placed into a cassette. The following steps were performed in the dark room; medical xray film (AGFA) was placed onto the nitrocellulose membrane, and exposed for various
times (15 seconds, 1 minute, 3 minutes, 15 minutes and overnight). After exposure, the
medical x-ray film was placed in developer solution (solution A 80%, solution B 20%)
for 2 minutes and agitated, washed by water and then placed in fixer solution (fixer
100ml and 'double distilled de-ionised water (ddH2 0) 300ml) for 2 minutes, washed
(water) and air dried.

3.4.1.8. Stripping the nitrocellulose membrane to re-probe with the Pax7 antibody
The nitrocellulose membrane was immersed in stripping buffer (1 OOmM Bmercaptoethanol, 2% SDS, 62.5Mm Tris-HCl pH 6.7), incubated at 50°C for 30 minutes
with agitation. The membrane was washed 2x in TBS for 10 minutes at room temperature
on an orbital shaker, blocking buffer (1x TBS pH 7.4, Tween-20 0.1% and 5% dry nonfat skim milk) was applied to the membrane, incubated for 2 hours at room temperature
on an orbital shaker. Pax7 monoclonal antibody (DSHB) was diluted 1:20 in 1x TBST
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and added to the nitrocellulose membrane, incubated overnight at 4 oc on a rotating
platform. The membrane was washed sixteen times in lx TBST for 15 minutes on an
orbital shaker at room temperature.

The secondary antibody Immunoglobulin G-horseradish peroxidase (lgG-HRP) (diluted
1:2000 in lx TBST) was applied and visualised using the ECL kit as described earlier
(Section 3.4.1.7.). The medical X-Ray film was exposed to the membrane and developed
and air dried as before.

Once confirmation of protein expression for each Pax7 transcript was achieved, NIH3T3
cells trasfected with alternate Pax7 transcripts as well as cells transfected with the vector
alone and untransfected cells were subjected to chromatin immunoprecipitation (ChiP)
studies.

3.4.2. Pax7 transcript RT -PCR
3.4.2.1. RNA extraction
RNA was isolated from transfected and untransfected control NIH3T3 mouse
embryonic fibroblast cells utilising an Aurum RNA extraction Kit (BioRad) as per
manufacturer's instructions. RNA samples were then treated with DNase 1 utilizing the
DNA-free™ Kit (Ambion) to eliminate DNA from each RNA preparation. RNA
concentration was determined by measuring absorbance at 260nm [A260] using a
biophotometer (eppendorf). Extracted, DNase treated RNA isolated from cells transfected
with each alternate Pax7(a-d) transcript or vector transfected or untransfected cells were
used in RT-PCR studies to confirm Pax7 expression in transfected cells.

3.4.2.2. Reverse transcription of RNA from NIH3T3 cells transfected with Pax7(a-d)
transcripts
RNA was converted to eDNA utilizing Omniscript Reverse Transcriptase (Qiagen).
Conditions were; reaction volumes of 20J..d containing final concentrations of lJ.!g total
RNA template, lJ.!M Oligo-dT primer, 0.5mM of each dNTP (Qiagen), lx reverse
transcriptase-buffer (RT-Buffer) (Qiagen), RNase out (lOU, Qiagen), Omniscript reverse
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transcriptase (4 U, Qiagen). Each reaction was incubated for 60 minutes at 37°C, in the
PCR machine.

3.4.2.3. Polymerase Chain Reaction (PCR) to detect Pax7 transcript expression
A

region

of

Pax7

was

amplified

utilizing

CACCGACTCTGGATTCGTCTCCAGCGTG-3'

and

forward
reverse

pnmer

F4:

primer Pax7R:

5 '5'-

ACAACCATGAGAAACACGGAGC-3', that span the 5' paired box region of Pax7. RTPCR reactions were conducted using an MJ Research PTC-200 Peltier thermal cycler
with a heated lid. Samples were set up on ice and loaded into a pre-heated thermal cycler
(95°C).

Conditions for PCR reactions were; 20fll reaction volumes containing 1/10 of the final
concentration

of

eDNA

(0.1 f.! g),

1J.!M

CACCGACTCTGGATTCGTCTCCAGCGTG-3'

forward
and reverse

primer

F4:

primer Pax7R:

5 '5'-

ACAACCATGAGAAACACGGAGC-3', 1x PCR buffer, 1x.Q solution, 200mM of each
dNTP and Taq DNA polymerase (2.5 U/reaction). Optimal cycling conditions were; an
initial denaturation of 94 oc for 3 minutes, followed by 45 cycles of 94 oc for 30 seconds,
50°C for 30 seconds, 72°C for 30 seconds, then a final extension at 72°C for 10 minutes.

R.T-PCR products for each

Pax7 transcript were then subjected to agarose gel

electrophoresis. Products were visualized on ethidium bromide stained gels relative to
DNA size ladders and photographed using a UV Biorad Gel Doc System.

3.4.3. Immunocytochemistry of transfected cells to detect Pax7 expression
3.4.3.1. Immunocytochemistry
Cells were transferred to Lab-Tek® II Chamber Slides™ (Nalge Nunc International) at
a concentration of 1x105cells/ml and grown overnight. Cell culture medium was removed
from transfected NIH3T3 cells, and cells were washed 3 times with sterile 1x TBS.
Freshly prepared 4% paraformaldehyde in PBS was added to the cells and incubated for
10 minutes at room temperature. The paraformaldehyde was then removed. Cells were
rinsed three times in 1x TBS and quenched for 10 minutes in 3% hydrogen peroxide for
depletion of endogenous hydrogen peroxide. Cells were rinsed in lx TBS. 1x TBST
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supplemented with 1% normal goat serum (NGS) and 1% fetal calf serum (FCS) was
used for blocking non-specific reactions for 1 hour at room temperature. Primary
antibodies, Anti-V5 (1 :500 Invitrogen) or Pax7 (1: 10 DSHB) diluted in TBST
supplemented with 1% NGS and 1% FBS were applied to cells and incubated overnight
at 4°C. Cells were washed with 1x TBS and the secondary antibody, IgG-linked to biotin
(Lsab, Biorad) diluted in 1x TBST, was applied to cells and incubated for 1 hour at room
temperature. Three 1x TBS wash steps followed for 5 minutes and then streptavidin
linked to horse-radish peroxidise (Lsab, Biorad) diluted in 1x TBS was applied to the
cells and incubated for 1 hour at room temperature. A colorimetric reaction was obtained
by application of 3,3-diaminobenzidine (DAB, Dako) to the cells for 1-2 minutes. Cells
were washed in 1x TBS and 1x Tris normal saline (TNS), mounted using glycine
(gelatine 10g/ml, glycerine 70ml, phenol 1ml), coverslipped and viewed with an
Olympus Bx41 microscope.

3.4.3.2. Photography
Immunocytochemistry results were photographed using a Leica DC300 digital camera
mounted on an Olympus Bx41 microscope at 40x magnification.

3.5.

CHROMATIN IMMUNOPRECIPITATION

3.5.1. DNA-shearing optimization
T25 flasks containing untransfected NIH3T3 cells (lx106/ml) were utilized to
determine optimal sonication conditions. The complete experimental procedure was
performed on ice. Crosslinked protein-DNA cell lysates extracted from untransfected
NIH3T3 cells by the addition of 1ml SDS lysis buffer containing 10mM EDTA, 50mM
Tris-HCl, pH 8.1 and 1% SDS, were sheared utilising an Ultrasonicator (Sonics Vibra
cell™) for the following times; 60 seconds, 120 seconds, 160 seconds, 200 seconds and
300 seconds. An unsonicated sample was included as a control to assess successful
sonication procedures. Sonicated samples were centrifuged at 14 OOOrpm for 10 minutes
at 4°C, the supernatant was collected and 5M NaCl (600 f.!l) was added to each sample,
vortexed briefly and incubated overnight at 65°C (to de-crosslink protein-DNA
complexes). The de-crosslinked protein-DNA complexes were then pelleted at
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14 OOOrpm for 30 seconds at room temperature, protein was digested with lOJll of 0.5M
EDTA, 20Jll of 1M Tris-HCl, pH6.5 and 30Jll of 10mg/ml Proteinase K (Qiagen), by
incubation for 1.5 hours at 45°C. The digested protein samples were then subjected to
DNA purification utilizing the QIAquick PCR Purification kit (Qiagen) as pet
manufacturer's instructions (Section 3.5.6.1.). Purified DNA products were resolved by
agarose gel electrophoresis to visualise the optimal sonication time required to shear
crosslinked protein-DNA complexes to fragments of approximately 200-1000 bp.
Sonicated, purified DNA (5Jll) were diluted in 6x loading buffer and applied to a 1%w/V
agarose gel and electrophoresed in TAE buffer containing 5Jlg/ml ethidium bromide and
run at a constant 105V for 1 hour. Sizes of products were estimated by comparison to a
DNA size ladder (1 Kb Plus). The gel was viewed on a UV Biorad Gel Doc System and
photographed.

The sonication time of 120 seconds showed adequate genomic shearing evidenced by
DNA fragments between 200-1000 bp and was selected as the optimal sonication time for
future ChiP experiments.

3.5.2. Chromatin crosslinking and lysis of nuclei
. Transfected cells (lx106cells/ml) were treated with 1% formaldehyde in 10mls ofPBS
and incubated for 10 minutes at room temperature. Glycine at a final concentration of
0.125M, was applied to the cells to prev~nt Pax7-isoforms from over-fixing to the DNA.
Cells were then washed twice with lOml ice cold PBS. Transfected cells were
resuspended in SDS lysis buffer (lOmM EDTA, 50mM Tris-HCl, pH 8.1 and 1% SDS)
supplemented with proteinase inhibitors (Protease inhibitor cocktail (PIC) 20x,
Phenylmethyl Sulfonyl Fluoride, PMSF 200x) and incubated on ice for 10 minutes to lyse
nuclei.

3.5.3. DNA-shearing and pre-clearing
Cell lysates were sonicated for 120 seconds (according to optimisation procedures
described in Section 3.5 .1. ), centrifuged at 14 OOOrpm for 10 minutes at 4 °C, then
supernatant was collected and diluted with 600Jll ChiP dilution buffer (0.001% SDS,
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1.1% Triton X 100, 1.2mM EDTA, 16.7mM Tris-Cl pH 8.1, 167mM NaCl), containing
1x PIC and pre-cleared (to reduce non-specific immunoprecipitation) by the addition of
30J.!l DNA/Protein A Agarose beads (Santa Cruz Biotechnology). The samples were
incubated on a rotating platform for 30 minutes at 4°C, centrifuged at 1200rpm for 1
minute and the supernatant was collected.

3.5.4. Immunoprecipitation ofPax7-DNA complexes
Supernatants from pre-clearing were divided between experimental samples and control
(no antibody) samples. The V5 antibody (2Jlg) was added to each experimental sample.
All samples were incubated overnight on a rocking platform at 4 °C. DNA/Protein A
Agarose beads (60J.!l) were added to each sample followed by a 2 hour incubation
(rocking platform at 4°C) and then centrifuged at 1200rpm for 1 minute at 4°C. The
beads were washed with 1ml ice cold low salt buffer (0.1% SDS, 1% Triton, 2mM
EDTA, 20mM Tris, 150mM NaCI), then with lml ice cold high salt buffer (0.1% SDS,
1% Triton, 2mM EDTA, 20mM Tris, 500Mm NaCl), and then three times with 1ml ice
cold TE buffer (lOmM Tris, 1mM EDTA). Each wash was incubated for 5 minutes on a
rotating platform at 4°C followed by centrifugation at 1200rpm for 1 minute at 4°C; the
supernatant was discarded each time and the DNA/Protein A Agarose beads retained.
Antibody/protein/DNA complexes were then eluted from beads by addition of 2x 250J.!l
elution buffer (0.1M sodium hydrogen carbonate, 1% SDS), the mixture was shaken
gently and incubated for 15 minutes at room temperature, followed by centrifugation at
1200rpm for 1 minute. The supernatant was collected and transferred into a new tube.

3.5.5. Reverse crosslinking ofPax7-DNA complexes
· To reverse formaldehyde crosslinks, NaCl (final concentration 1x10-5M) was added,
followed by overnight incubation at 65°C. Samples were then centrifuged (14 OOOrpm,
for 1 minute), protein was digested with 1nM Proteinase K, 30nM EDTA and 0.2nM
Tris-HCl and incubated at 45°C for 1.5 hours.
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3.5.6. DNA purification
DNA was purified using either the QIAquick spin column (Qiagen) or by Phenol
Chloroform extraction.

3.5.6.1. Purification kit
Digested protein samples were resuspended in 800f!l PB buffer and applied to
QIAquick® spin columns (Qiagen), centrifuged at 13 OOOrpm for 60 seconds, washed
with 750f!l DNA cleanup buffer (PE), centrifuged at 13 OOOrpm for 60 seconds, then for
an additional 1 minute (to remove residual ethanol from the PE buffer). Samples were
then eluted with ddH20 (50f!l), incubated for 1· minute at room temperature and
centrifuged (13 OOOrpm, for 1 minute). Purified DNA samples were subjected to PCR
utilising primers specific for the representative target genes chosen for investigation
(Table 3.1.).

3.5.6.2. Phenol chloroform isoamyl DNA purification
Following proteinase K digestion, samples were resuspended m Tellurium (TE)saturated phenol: chloroform: isoamyl alcohol (25:24:1) (500f!l), vortexed for 30 seconds
and centrifuged (14 OOOrpm, for 5 minutes). The upper aqueous layer of each sample was
placed into a new tube, followed by the addition of 100% ethanol (1 OOOf!l) supplemented
with 3M Sodium Acetate (NaCH3 C02) (50f!l). Samples were inverted 6 times and
incubated overnight at -20°C. Samples were then· centrifuged (14 OOOrpm, 4°C, 15
minutes), supernatant was removed and samples were air dried for 10 minutes then
resuspended in 50f!l TE buffer. Samples were subjected to PCR utilising primers specific
for the representative target genes (Table 3.1.).

3.6.

ChiP-PCR to detect bound target genes
PCR was performed using specific primers as indicated in (Table 3.1.) Optimal

conditions for ChiP-PCR were; reaction volumes of 20111 containing final concentrations
of lf!g/ml DNA template, lOf!M each primer, 200f!M each dNTP, lx PCR buffer, lx Q
solution, Taq DNA polymerase (2.5 U). Optimal cycling conditions were; an initial
denaturation step of 94°C for 3 minutes, followed by 35 cycles of 94°C for 1 minute

39

Chapter Three: Methods

(denaturation), primer-specific annealing temperature (Table 3.1.) for 1 minute, 72°C for
1 minute (extension), then a final extension at 72°C for 10 minutes. The PCR products
were separated by agarose gel electrophoresis.

A positive control was also amplified using input samples (untransfected NIH3T3 cell
DNA) that were crosslinked, lysed, sonicated for 120 seconds, de-crosslinked, protein
digested and DNA purified to determine if the primers designed for each target gene
chosen for investigation (Table 3.1.) successfully amplified the target genes (produce
PCR products of the correct size). Amplified input samples were subjected to agarose gel
electrophoresis to confirm the presence and sizes of the amplified target genes.

Table 3.1. Primer sequences, PCR annealing temperatures and expected sizes of
"PCR products.
Gene

CntfR

Primer sequences

F:S'-TTCCCAGAGCCCAGTAGGAG-3'

Amplicon

PCR annealing

size (bp)

Temperature

593

58°C

775

56°C

378

56°C

601

56°C

725

56°C

R:S'-CGGCAAGCACAGCACAGCAG-3'
Eya4

F:S'-TTGGAGTCAGGAGCAGGAC-3'
R:S'-ACACAAACTCGTACACCCAC-3'

Gbxl

F:S'-TGCTACACTACCTCTCCCAG-3'
R:S'-TTCTTAGAGCAGCCTTGAGC-3'

Rasa3

F:S'-TGCTACACTACCTCTCCCAG-3'
R:S'-TTCTTAGAGCAGCCTTGAGC-3'

Kcnk2

F:S'-TGCATCTAAGCTGAGTGTGC-3'
R:S'-AAATAGGAGGAACACTGGAG-3'

Prrxl

F:S'-AAATACGTTCAGACCACTCC-3'

470
50°C

R:S'-ACCTATACACAGAGTGACTG-3'
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3.7. REGULATION OF TARGET GENES IN Pax7dTRANSFECTED CELLS
3.7.1.1. RNA extraction, DNase treatment of RNA and RNA concentration
RNA was isolated from P19 mouse embryonic cells transfected with Pax7d utilising the
RNA extraction Aurum Kit (Qiagen) as per manufacturer's instructions. RNA samples
were then treated with DNase 1 utilizing the DNA-free™ Kit (Qiagen) and RNA
concentration was determined by measuring absorbance at 260nm [A26o] using a
biophotometer (eppendort). Extracted, DNase treated RNA was used in RT-PCR
reaction studies to determine regulation of target genes in transfected cells. Untransfected
Pl9 cells were utilized as a negative control.

3.7.1.2. Reverse transcription of RNA from P19 cells transfected with the Pax7d
transcript
RNA was first converted to eDNA utilizing Omniscript Reverse Transcriptase kit
(Qiagen). Optimal conditions for converting RNA to eDNA were; reaction volumes of
20J..1l containing final concentrations of 1J..lg total RNA template, 1J..1M Oligo-dT primer,
0.5mM of each dNTP (Qiagen), 1x RT-Buffer (Qiageil), RNase out (10 U, Qiagen)~
Omniscript reverse transcriptase (4 U, Qiagen). Each reaction was incubated for 60
minutes at 37°C.

3.7.1.3. Polymerase Chain Reaction (PCR) to assess target gene expression
The eDNA of target genes was amplified utilizing primer pairs corresponding to the 5'flanking region or sequences beyond the 3' end of target genes (Table 3.2.). Optimal
conditions for PCR were; reaction volumes of 20J..1l containing 1/10 of the final
concentration of eDNA (0.1J..lg), 1J..1M primers, 1x PCR buffer, 1x Q solution, 200mM of
each dNTP and Taq DNA polymerase (2.5 U/reaction). Optimal cycling conditions were;
94°C for 3 minutes, followed by 45 cycles of 94°C for 30 seconds, 50°C for 30 seconds;
72°C for 30 seconds, then a final extension at 72°C for 10 minutes and a cool down step
at 10°C for 10 minutes. RT-PCR products for each target gene were resolved by agarose
gel electrophoresis as described in (Section 3.2.3.).
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P19 cells transfected with the Pax7d transcript were subjected to RT-PCR for mRNA
expression levels as described in (Section 3.4.2.) and immunocytochemistry as described
in (Section 3.4.3.). Once expression of Pax7 and V5 were confirmed, cells were treated
for ChiP as described in (Sections 3.5.2.-3.5.5., 3.5.6.2) and finally amplified by PCR
(Section 3.6.). Due to time constraints a western blot analysis of the Pax7d transcript was
not performed.

Table 3.2. Primer sequences and expected sizes of RT -PCR products.
Gene

Primer sequences

Amplicon
size (bp)

CntfR

F:S'-ACACGCAGAAACACAGTCCAC-3'

274

R:S'-TTGGAGCGGCAGCTGAGCAC-3'
Eya4

F:S'-GTAAAGAAAACGTGCCCAG-3'

258

R:S'-AAAAGTGTCAAGCGCTCC-3'
Gbxl

F:S'-ACGCTGAGGAGCTGCTGC-3'

163

R:S'-TCGCTGCCTGCTGGGTCTC-3'
Rasa3

F:S'-AGGGACACATGGTTCCAGC-3'

162

R:S'-GTTCACAATGGGGAGACC-3'
Kcnk2

F:S'-TCAAGTTAGTCACTGGGAC-3'
R:S'-ATGTGTCTTCCACTTTGGC-3'
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Chapter 4

RESULTS

4.1

Introduction

To determine the target genes that each Pax7 isoform selects, chromatin
immunoprecipitation (ChiP) was performed on Pax7-isoform-DNA (target gene)
complexes isolated from mouse Nlli3T3 embryonic fibroblast cells transfected with
individual Pax7(a-d)-pcDNA3.1D/V5-His vector transcripts.

Transfected cells were stably selected with G418 for 28 days, assessed for Pax7 -vector
and Pax7 expression by western blot, then bound target genes of each isoform were
analysed by chromatin immunoprecipitation. Pax7 -vector-target-gene complexes were
immunoprecipitated with the anti-V5 antibody, to ensure only Pax7 isoforms expressed
from the Pax7-vector constructs (and not endogenous isoforms) were selected. Previously
identified downstream target genes chosen for investigation of Pax7 isoform binding
were: CntjR, Eya4, Gbxl, Prrxl, Rasa3 and Kcnk2.

4.2.

AIM: To identify Pax7 isoform-specific differences in target gene
selection.

4.3.

Pax7(a-d)-vector transfection

4.3.1. Successful isolation of DNA containingPax7(a-d)-vector constructs

In previous studies, full length Pax7(a-d) transcripts were cloned into the
pcDNA3.1 DIV5-His-TOPO expression vector and sequenced to confirm correct

orientation and sequence. Here clones were amplified in E. coli, and then individual
clones were picked at random, grown in LB broth and vectors were isolated utilizing a
miniprep plasmid purification kit (Qiagen). Agarose gel electrophoresis was performed tci
assess the quantity and quality of Pax7(a-d)-pcDNA3.1DIV5-His-TOPO vector DNA
(Figure 4.1.). Bands were observed at 12000 bp, 7000 bp and 5000 bp indicating circular
plasmid forms of the cloned DNA.
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1

2

3

4

~

12000bp
7000bp
5000 bp
Figure 4.1. Agarose gel electrophoresis of purified Pax7(a-d)-pcDNA3.1DIV5-HisTOPO vector DNA: (Left to right) Lane 1 (Pax7d-), 2 (Pax7c-), 3 (Pax7b-) and 4
(Pax7a-) vector constructs respectively. DNA bands were observed at approximately
12000 bp, 7000 bp and 5000 bp. Lane~. displays the lKb Plus standard DNA ladder
(Invitrogen).
Results indicate successful isolation of plasmid vectors, given that the set of three large
DNA bands at around 12000 bp, 7000 bp and 5000 bp are indicative of circular plasmid
DNA in various conformations.

4.3.2. Polymerase Chain Reaction (PCR) of Pax7(a-d)-pcDNA3.1DIV5-His-TOPO
eDNA constructs
PCR was performed on isolated purified plasmid DNA using vector specific primers
that span the vector and Pax7 insert at the 5' end and the vector at the 3' end to determine
the size and orientation of alternate Pax7 transcript vector inserts. PCR products of the
correct size of 1650 bp were obtained for each cloned transcript (Figure 4.2.).

B 1

2

3

4

~

+--- 1650bp

Figure 4.2. Agarose gel electrophoresis of isolated Pax7-vector DNA amplified by
PCR utilizing Pax7-vector specific primers (F4 and BHG respectively): Lanes 1, 2, 3,
and 4 display alternate Pax7 transcripts inserted correctly into the pcDNA3.1D/V5-HisTOPO vector. (Left to right) Lane 1 (Pax7d), Lane 2 (Pax7c), Lane 3 (Pax7b), and Lane
4 (Pax7a). Lane~. the 1 Kb Plus standard DNA ladder. Lane B, blank sample consisting
of all PCR reaction constituents excluding template DNA (negative control). All
transcripts display the predicted size of 1650 bp.
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4.4.

Stable transfection studies

4.4.1. Cell morphology
In order to assess the DNA-binding differences between each Pax7 isoform, single

Pax7(a-d) transcripts cloned into the pcDNA3.1D/V5-His-TOPO expression vector were

transfected into NIH3T3 mouse embryonic fibroblast cells. Constructs that had stably
integrated into the mouse NIH3T3 genome were selectively grown in cell culture mediuni
containing G418.

NIH3T3 cells transfected with the pcDNA3.1 DIV5-His-lacZ vector alone, was used as a
negative control. Photographs of clones 14 days after stable transfection of each Pax7
transcript and vector alone were taken utilizing a Leica DC300 digital camera (Figure
4.3.). No difference in morphology was observed between cells transfected with each
transcript versus vector transfected cells (Figure 4.3.).

c.

A.

-

-

-

E.

D.

Figure 4.3. Micrograph images of stable Pax7-vector transfected clones (day 14)
(20x magnification): (A) Cells transfected with vector alone. NIH3T3 cells transfected
with (B) Pax7a transcript; (C) Pax7b transcript; (D) Pax7c transcript; (E) Pax7d
transcript. Scale bar = 40!lm.
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4.5.

Confirmation of Pax7 protein expression in stably transfected
cells

After selection of transfected cells, Pax7 protein expression was assessed by western
blot methodology.

4.5.1. Western blot
Western blot was performed to determine the protein expression levels in cells stably
transfected with each Pax7 transcript or with vector alone. Initially the nitrocellulose
membrane was probed with the anti-V5 antibody, to ensure that cells express full-length
Pax7 isoforms fused to the V5 epitope tag transcribed from the vector (Figure 4.4. A).
The membrane was then stripped and re-probed with the Pax7 antibody to further
confirm protein identity (Figure 4.4. B). A band corresponding to a Pax7-V5-His-fusion
protein was observed on the western blot at the correct size of 59kDa (Figure 4.4. A,
Lane 3). A similar band was observed when the membrane was probed with the Pax7
antibody (Figure 4.4. B, Lane 3). Positive Pax7 expression at the correct size of 59kDa
was obtained for the Pax7c isoform only (Figure 4.4. A and B, Lane 3).
1

2

3

4

5 6

1

M

2

3

4

5

6

M

A.
59kDa
59kDa

Figure 4.4. Western Blots of Pax7-V5-His-fusion protein probed with V5-antibody
(A) or Pax7 antibody (B):(Left-right) Lane 1, Pax7a; Lane 2, Pax7b; Lane 3, Pax7c;
Lane 4, Pax7d; Lane 5, Control vector; and Lane 6, Untransfected NIH3T3 cells. (A)
Positive expression observed for the Pax7c isoform (Lane 3) at the correct size of 59 kDa
when probed with the V5 antibody, or (B) with the Pax7 antibody. Lane M, standard
protein size ladder.
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The size of 59kDa is anticipated ·since the Pax7 protein is 30kDa in size and when fused
to the V5 and His epitope tags, a fusion protein of 59kDa is produced. From western blot
it was apparent that specific Pax7 -isoform-epitope-tag expression was achieved for the
Pax7c transfectant (Figure 4.4. A. Lane, 3) and possibly Pax7 expression for the Pax7a

transfectant (Figure 4.4, B. Lane, 1). No endogenous Pax7 appeared to be consistently
present in any of the cells (Figure 4.4. A and B Lanes 1-6). Since the Pax7c isoform
demonstrated positive Pax7-V5-His protein expression, the isoform was subjected to
chromatin immunoprecipitation and PCR (Section 4.7.2.) to observe target gene
selection.

4.6.

Sonication optimization of protein-DNA complexes for ChiP

4.6.1. Determining DNA shearing optimization conditions
To perform chromatin immunoprecipitation it was necessary to optimize the shearing of
genomic DNA into 200-1000 bp fragments to ensure that analysed protein-DNA
interactions are confined to distinct chromosomal regions. The optimal sonication time
was chosen on the basis of obtaining small fragments of sonicated DNA between

200~

1000 bp. Sonication optimization was performed on untransfected NIH3T3 cells (Figure
4.5.). As this had not been performed on cultured celllysates in our laboratory before, but
only on embryonic tissue, it was necessary to attempt sonication at a number of different
times and determine the time at which optimal DNA shearing was obtained.
12

3456M

Figure 4.5. DNA shearing conditions for NIH3T3 cells: A volume of 1ml was pulsed
at 30% power for 60 seconds (Lane 6), 120 seconds (Lane 5), 160 seconds (Lane 4), 200
seconds (Lane 3) and 300 seconds (Lane 2) on ice with 30 seconds rest between each
pulse. An unsonicated sample was used as a control (Lane 1). Samples were purified then
subjected to agarose gel electrophoresis (1 %), and visualized by a gel doc UV illuminator
system following ethidium bromide staining of the gel. Lane M, 1Kb Plus standard DNA
ladder (Invitrogen).
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Results indicate that the maximum amount of DNA at the required size between 2001000 bp was obtained after 120 second sonication time (Figure 4.5. Lane, 5).

4.7.

PCR of chromatin immunoprecipitated NIH3T3 cells

4.7.1. PCR of untransfected chromatin immunoprecipitated NIH3T3 cells (Input
chromatin)
Primer pairs oftarget genes CntjR, Eya4, Gbxl, Prrxl, Rasa3 and KcnK2 (Table 3.1.),
were first trialled against a positive control (input sample) containing chromatin isolated
from untransfected NIH3T3 cells subjected to formaldehyde crosslinking (Methods
section 3.5.2.), sonication (Methods section 3.5.3.), de-crosslinking (Methods section
3.5.5.) and DNA purification (Methods section 3.5.6.2.) without immunoprecipitation.
PCR primer pairs correspond to the 5'- flanking region or sequences beyond the 3' end of
target genes for target gene amplification (Table 3.1.). The PCR reactions generated
products of the expected size for most target genes (Figure 4.6.).

Bl B2 B3B4B5B6M

Figure 4.6. PCR products amplified from untransfected NIH3T3 cells (input
sample): (Left-right) Lanes 1, 601 bp (Rasa3); 2, 775 bp (Eya4); 3, 725 bp (KcnK2); 4,
378 bp (Gbxl); 5, no product is visible (Prrxl) and 6, 593 bp (CntjR). Lanes labelled B
are negative controls consisting of all PCR reaction constituents minus the template
DNA. No amplification was observed for these samples. Lane M, 1Kb Plus standard
DNA ladder. Further optimisation for the Prrxl gene was conducted until specifically
designed primers successfully amplified the target gene region.
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Results indicate amplification of target genes chosen for investigation, demonstrating that
primers specifically designed for most target genes successfully amplified target gene
regions and are therefore appropriate for later stages of the investigation when the
presence ofthese gene regions boundby Pax7 isoforms were to be assessed.

4.7.2. PCR of stably transfected Pax7c chromatin immunoprecipitated cells
Since positive Pax7c expression was obtained by western blot, the cell line transfected
with the Pax7c-vector construct was subjected to chromatin immunoprecipitation to
observe target gene selection (Figure 4.7.). Chromatin immunoprecipitation oftransfected
cells was performed with the V5 antibody which will bind to the V5 epitope tag on the
Pax7c-vector fusion protein. The immunoprecipitated chromatin DNA was analyzed by
PCR for the presence of regulatory sequences of selected target genes. This was achieved
utilizing primer pairs corresponding to the 5'-flanking region or sequences beyond the 3'
end oftarget genes as described above (Table 3.1.).

Upon completion of this process, negative results were obtained. Results show no target
genes were amplified from DNA isolated from chromatin immunoprecipitates when this
process was performed on Pax7c-vector transfected cells using the V5 antibody (Figure
4.7. Lane, +). Furthermore, no PCR products were visible even when DNA from cells
transfected with Pax7c-vector constructs but not immunoprecipitated with V5 (no
antibody control) were used (Figure 4.7.Lane, -).In contrast, products of expected sizes
were visible for input chromatin (untransfected NIH3T3 cells) not precleared, not
immunoprecipitated with V5, washed and eluted (Figure 4.7. Lane, I). No products were
visible for blank samples that consisted of all PCR reaction components minus template
DNA (Figure 4.7. Lane, B).
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BI -+
CntfR-+-1111-593 bp
Eya4
775 bp
Gbxl
378 bp
Rasa3
1 bp

Kcnk2
Prrxl
Figure 4.7. ChiP-PCR to assess target gene selection by Pax7c-vector constructs
immunoprecipitated with the VS antibody: (Top-bottom) CntfR, Eya4, Gbxl, Rasa3,
Kcnk2 and Prrxl (Left-right) (B) blank PCR samples consisting of all PCR reaction
constituents minus template DNA, no products are visible. (I) Input samples showing
visible products of target genes of expected size (Top-bottom) CntfR, 593 bp; Eya4,
775 bp; Gbxl, 378 bp; Rasa3, 601 bp; Kcnk2, 725 bp and Prrxl, 470 bp. (-)No antibody
controls amplified with target gene primer pairs. For all target genes, no PCR products
are visible. (+) Pax7c isoform immunoprecipitated with VS antibody and amplified with
target gene primer pairs (Top-bottom) CntfR, Eya4, Gbxl, Rasa3, Kcnk2 and Prrxl.
Negative results show no target genes were selected by Pax7c.
Results indicate that no DNA was amplified when isolated from immunoprecipitated
samples, since there are no visible PCR products for the set of target genes chosen for
investigation.

In

contrast,

input

chromatin

(untransfected

NIH3T3

cells

not

immunoprecipitated) successfully amplified each target gene (Figure 4.7. Lane, I).

Second ChiP attempt
Given that there appeared to be Pax7a-vector protien expression by western blot probed
with the Pax7 antibody (Figure 4.4. B, Lane 1), the cells transfected with Pax7a-vector
construct were subjected to chromatin immunoprecipitation and a PCR was performed
with specific primers (Table 3.1.) designed to amplify the promoter region of CntfR
(Figure 4.8. A) and Rasa3 (Figure 4.8. B) genes to observe whether these genes were
selected by Pax7a. Results show that these target genes were not selected by Pax7a
(Figures 4.8. A and B, Lane+). In contrast, input chromatin (untransfected NIH3T3 cells)
amplified CntfR and Rasa3 target genes and produced a PCR product of the correct size
(Figure 4.8. A and B, Lane I respectively).
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A.

B.

BI -+

Pax7Ba -

Pax7Ba

•11111--593 bp

B I-+
•11111--601 bp

Figure 4.8. ChiP-PCR for selection of (A) CntjR and (B) Rasa3 by Pax7a identified
by immunoprecipitation with the V5 antibody: (A) and (B) Lane (B) blank PCR
sample consisting of all PCR reaction constituents minus template DNA, no products are
visible. (A) (Left-right) (I) Input sample showing a visible product of expected size
593 bp (CntjR). (-)No antibody control amplified with CntjR primer pairs generated no
PCR product. (+) cells transfected with Paxla-vector construct immunoprecipitated with
V5 antibody and amplified with CntjR primer pairs, generated no PCR product.
(B) (Left-right) (I) Input sample showing a visible product of expected size 601 bp
(Rasa3). (-) No antibody control amplified with Rasa3 primer pairs generated no PCR
product. (+) cells transfected with Paxla-vector construct immunoprecipitated with V5
antibody and amplified with Rasa3 primer pairs generated no PCR product. No other
target genes were attempted for the Pax7a-transfected cells.
Summary
Although results show that ChiP methodology was not successful in isolating target
genes bound by Pax7, several reasons for no target gene amplification were possible.
Firstly, it was possible that not all cells were expressing high levels of Paxl. Therefore,
to test this the Pax7-vector transfected cells were subjected to mRNA analysis. The
Pax7c-vector transfected cells as well as control vector transfected cells were also
subjected to immunocytochemistry to determine expression levels and the ratio of cells
stably transfected and expressing the Pax7c-vector fusion protein containing the V5
epitope.

Moreover, secondly, it was possible that negative results were obtained due to losses of
DNA throughout the ChiP procedure.
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4.8.

Optimization of DNA extraction for ChiP methodology

4.8.1. Confirming the presence and quantity of DNA throughout the chromatin
immunoprecipitation procedure
· Because no PCR products were evident from ChiP isolated DNA, the amount of DNA
material was then assessed at each step to determine whether DNA was lost during the
multi-step procedure (Methods section 3.5.). When DNA analysis was performed on
untransfected sonication trials, loss of DNA was apparent (Figure 4.5.). Thus to try to
correct this, DNA concentration was analysed at each step prior to immunoprecipitation
using NIH3T3 control cells.

The amount of DNA was analyzed after cell collection from cell culture flasks by either
accutase treatment or by applying nuclear lysis buffer directly to cells (Figure 4.9. A-C.).
DNA was then analyzed after optimizing protein-DNA sonication shearing conditions for
each method of cell collection (Figure 4.9. B and C respectively). The quantity of DNA
was greater when nuclear lysis buffer was applied directly.to the cells (Figure 4.9. B)
compared to DNA levels after cells were removed by accutase (Figure 4.9. C).

The presence of DNA was again analyzed after DNA was purified (Methods section
3.5.6.) by either the PCR DNA purification kit (Qiagen) or by phenol chloroform isoamyl
extraction (Figure 4.9. D and E respectively). The quantity of DNA was greater when
phenol chloroform isoamyl extraction was used (Figure 4.9. Image D) compared to DNA
levels obtained as a result of DNA purification by the DNA purification kit
(Figure 4.9. E).

52

Chapter Four: Results

1

M

1650 bp

1650 bp

bp
200bp

1 2

3 4

1 2

5 M

+--1650bp

3 4

5 M

1650 bp

200bp

+--200bp

Figure 4.9. Agarose gel electrophoresis images indicating the quantity of DNA at several
steps during the chromatin immunoprecipitation procedure: (Left-right) Lanes labeled M,
lkb Plus standard DNA ladder (Invitrogen). (A) displays the presence of DNA after cells were
lysed directly with nuclear lysis buffer (Lane 1). (B) Lane 1 displays cells directly lysed,
sonicated for 120 seconds followed by a centrifugation concentration step. Sheared chromatin
was between the expected sizes of 200-1000 bp. The presence of DNA after cells directly lysed
with nuclear lysis buffer were subjected to shearing at the following times, 60 seconds (Lane
3), 120 seconds (Lane 2). (C) displays the presence of DNA after cells treated with accutase
were subjected to shearing for 120 seconds (Lane 1), the smear was between the expected size
of 200-1000 bp. (B) and (C) indicate the presence and quantity of DNA is better when cells
were lysed by direct application of nuclear lysis buffer.
(D) displays the presence of DNA after DNA purification with the PCR purification Kit
(Qiagen).(Left-right) Lanes 1, 2, 3, 4, and 5 display cells to which nuclear lysis buffer was
directly applied followed by sonication for 300 seconds, 200 seconds, 160 seconds, 120
seconds and 60 seconds respectively. DNA smears were between expected sizes of 200-1000
bp. (E) displays the presence of DNA after DNA purification with phenol chloroform isoamyl
alcohol extraction. (Left-right) Lanes 1, 2, 3, 4 and 5 display DNA from cells to which lysis
buffer was directly applied followed by sonication for 300 seconds, 200 seconds, 160 seconds,
120 seconds and 60 seconds respectively. DNA smears were larger in size and DNA
concentration was greater.
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Results indicate that optimal DNA levels were obtained when cells were treated directly
with nuclear lysis buffer (Figure 4.9. B.), prior to sonication for 120 seconds. When this
step was followed by centrifugation, the DNA levels were concentrated allowing more
DNA to be used in later steps (Figure 4.9. B, Lane 1). Decrosslinked cells were finally
DNA purified by phenol chloroform isoamyl extraction procedure rather than by
purification kit as this extraction procedure yielded higher DNA concentrations (Figure
4.9. E) prior to proceeding with PCR analysis on chromatin immunoprecipitated cells.

Because DNA of target genes was not found bound by Pax7 in Pax7-vector transfected
cells, the levels of Pax7 expression and the number of Pax7 expressing cells were
assessed in NIH3T3 cells transfected with Pax7(a-d)-vector. It was felt that lack of ChiP
results might also be due to poor transfection efficiencies as individual clones had not
been selected during the selection process in G418 but rather all surviving cells had been
used.

4.9. Confirmation of Pax7 expression in Nffi3T3 cells
4.9.1. mRNA expression of Pax7 in transfected cells
Pax7(a-d) expression in NIH3T3 cells was assessed by RT-PCR after treatment with
DNase 1 to remove the DNA of the Pax7a-d-vector constructs from transfected cells.
Using primers F4 and Pax7R, a region of Pax7 was amplified that spans the 5' paired box
region. A PCR product was obtained of the expected size of 300 bp, in all cells
transfected 'with Pax7(a-d)-vector constructs (Figure 4.10. Lanes 1, 2, 3 and 4). In
contrast, no product was visible in untransfected NIH3T3 cells (negative control) (Figure
4.10. Lane, N) and in the blank sample containing all PCR reaction constituents minus
template DNA (Figure 4.1 0. Lane, B).
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Figure 4.10. RT -PCR products indicating Pax7 expression: RNA was extracted from
NIH3T3 cells treated with DNase 1 and converted into eDNA. Primers F4 and Pax7R
were employed to amplify a region of Pax7. (Left to right) Lanes 1, Pax7d; 2, Pax7c; 3,
Pax7b; and 4, Pax7a demonstrate a PCR product of 300 bp. Results from Pax7
transfected NIH3T3 cells compared to untransfected NIH3T3 cells where no product
(Lane N) is visible. No product is visible in the blank sample (Lane B). Lane M, lkb Plus
standard DNA ladder.
RT-PCR results confirm that Pax7-vector constructs were successfully expressed in
stably transfected NIH3T3 cells.

4.9.2. Immunocytochemistry

Positive Pax7c-vector expression evident from western blot and RT-PCR analysis of
transfected cells suggested that sufficient Pax7-vector expression was present in
transfected cells for chromatin immunoprecipitation to succeed. However, results
obtained from ChiP studies were negative. Therefore the expression of Pax7-vector
constructs in transfected cells was analysed by immunocytochemistry to assess the
number of cells expressing Pax7 as well as the level . of Pax7 expression.
Immunocyctochemistry was performed with mouse monoclonal Pax7 and V5 (lgG2a)
antibodies respectively. Since the cells transfected with Pax7c-vector construct appeared
to have the highest levels of Pax7-vector expression when assessed by western blot, only
cells transfected with Pax7c-vector construct were analysed by immunocytochemistry;
All cells that survive selection in 0418 should contain the Pax7c-vector construct stably
inserted into their genomic DNA and should therefore express the Pax7c-vector construct
via the cytomegalovirus (CMV) promoter present in the vector.

Since Pax7 is a transcription factor, the Pax7-vector fusion protein is likely to be
predominantly present in the nuclei of transfected cells when probed with either Pax7 or
V5 antibodies (Figure 4.11. C and D respectively). Since the pcDNA3.1D/V5-His-lacZ
vector alone would express lacZ with a V5-epitope-tag, the cells transfected with vector
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alone were expected to display predominant cytoplasmic epitope expression when probed
with the V5 antibody (Figure 4.11. B).

A.

~

+

B.

..

•

/

. D.

Figure 4.1J. Immunocytochemistry of NIH3T3 cells stably transfected with Pax7cvector construct or vector alone: Micrographs of immunocytochemistry showing
mouse monoclonal Pax7 or V5 antibodies, 40x magnification. (Left to right) (A) and (B)
NIH3T3 cells transfected with vector alone. (C) and (D) NIH3T3 cells transfected with
Pax7c-vector construct.(A) Vector alone visualized with Pax7 antibody, (B) Vector alone
visualized with V5 antibody, showing V5 expression in the nucleus and cytoplasm of the
cell; (C) Pax7c-vector transfected cells visualized with Pax7 antibody, showing Pax7
expression in the nucleus of the cell. (D) Pax7c-vector expression visualized with V5,
showing positive V5 expression in the nucleus of the cell. Scale bar = 20f.!m.

Results clearly indicate nuclear Pax7c-vector expression in NIH3T3 cells transfected with
the Pax7c-vector construct when reacted with either V5 or Pax7 antibodies (Figure 4.11.
C and D respectively). NIH3T3 cells transfected with the pcDNA3.1 DIV5-His-lacz
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expression vector alone demonstrate cytoplasmic V5-epitope tag expression (Figure 4.11.
B). Cells not transfected with the Pax7c-vector construct showed no Pax7c expression
(Figure 4.11. A). In all cases, cells transfected with either Pax7c-vector construct or with
vector alone demonstrate low levels of V5 expression in only 1 in 100 cells (Figure 4.11.
B, C and D).

These results provide a valid reason for the negative ChiP results. From these results it is
clear that not enough of the Pax7c isoform was present in sufficient numbers of
transfected cells to be found bound to DNA during the formaldehyde crosslinking
procedure (Methods section 3.5.2.). As a consequence of this firstly, cells were
retransfected.

Re-transfection and selection of each Pax7 transcript was conducted utilizing an
antibiotic concentration curve to assess the optimal concentration at which untransfected
cells would be lost. However, after four weeks of selection

~ll

cells remained completely

confluent. Immunocytochemistry was conducted on cells with the highest antibiotic
concentration applied. Unfortunately, re-transfected cells did not express any of the
isoforms. Therefore, all re-transfected cells were discarded since they were resistant to
the antibiotic. A third attempt to re-transfect was not performed due to time constraints.

4.10. Confirmation of Pax7 expression in a stably transfected P19 clone
A P19 embryonic carcinoma stem cell line previously transfected with Pax7d and
kindly donated by Vijesh Vaghjiani was utilized for further experiments.

4.10.1. mRNA expression of Pax7 in transfected cells
Pax7d expression in P19 cells was assessed by RT-PCR after treatment with DNase 1

to remove the DNA of the Pax7d-vector constructs from transfected cells. Using primers
F4 and Pax7R, a region of Pax7 was amplified that spans the 5' paired box region. A
PCR product was obtained of the expected size of 300 bp, in cells transfected with
Pax7d-vector construct (Figure 4.12. Lane, 1}. In contrast, no product was visible in
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untransfected P19 cells (negative-control) (Figure 4.12. Lane, N) and in the blank sample
containing all PCR reaction constituents minus template DNA (Figure 4.12. Lane, B).
B

1

N

+------ 300bp

Figure 4.12. RT -PCR product indicating Pax7 expression: RNA was extracted from
P19 cells treated with DNase 1 and converted into eDNA. Primers F4 and Pax7R were
employed to amplify a region of Pax7. (Left to right) Lane 1 demonstrates a PCR product
of 300 bp. Results from Pax7 transfected P19 cells compared to untransfected P19 cells
where no product (Lane N) is visible. No product is visible in the blank sample (Lane B).
Lane M, PUC DNA ladder (Fermentas).
RT-PCR results confirm that the Pax7d-vector construct was successfully expressed in
stably transfected P19 cells.

4.10.2. Immunocytochemistry
The expression of the Pax7d-vector fusion protein was visualized in transfected cells,
by immunocyctochemistry utilizing a mouse monoclonal Pax7 antibody or a V5 (IgG2a)
antibody respectively (Figure 4.13.).

Since the transfected cells were selected using G418 and an individual clone was selected
and assessed for Pax7 expression by RT-PCR, all cells that survived the selection process
should contain Pax7d-vector construct stably inserted into their genomic DNA, and thus
should express the Pax7d-vector construct via the CMV promoter present in the vector in
the nuclei of transfected cells.
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Figure 4.13. Immunocytochemistry of cells transfected with a Pax7d-vector
construct relative to untransfected P19 cells: Micrographs of immunocytochemical
staining utilizing mouse monoclonal Pax7 or V5 antibodies, lOOx and 40x magnification,
respectively. (Left to Right) (A) and (B) Untransfected P19 cells. (C) and (D) P19 cells
transfected with Pax7d-vector construct. (A) Untransfected P19 cells visualized with
Pax7 antibody, (B) untransfected cells with V5 antibody (C) Pax7d-vector fusion protein
visualized with Pax7 antibody, showing positive Pax7 expression in the nuclei of cells.
(D) Pax7d-vector fusion protein visualized with V5, showing positive V5 expression in
the nuclei of cells. Scale bar = 20J..Lm.
Results clearly indicate nuclear Pax7d-vector expression in Pl9 cells transfected with the

Pax7d-vector construct visualized with Pax7 or V5 antibodies (Figure 4.13. C and D).
Untransfected Pl9 cells showed no V5 or Pax7 expression (Figure 4.13. A and B).

Pax7d-vector transfected cells visualized with Pax7 or V5 show that approximately I :2
cells express the fusion protein (Figure 4.13. C, D). P19 cells transfected with vector
alone did not survive and no further transfections were conducted due to time constraints.
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Since the Pax7d-vector fusion protein was present in approximately half the cells, the
isoform was subjected to ChiP and PCR to observe target gene selection.

4.11. PCR of chromatin immunoprecipitated P19 cells
4.11.1. PCR of chromatin immunoprecipitations of cells stably transfected with
Pax7d-vector construct
Immunoprecipitations were performed with the V5 antibody against the V5-epitope-tag
present in the Pax7-pcDNA3.1D/V5-His fusion protein. The immunoprecipitated DNA
was isolated and purified using optimized procedures and analyzed by PCR for the
presence of regulatory sequences of selected target genes. This was achieved utilizing
primer pairs corresponding to the 5'-flanking region or sequences beyond the 3' end of
the target genes (Table 3.1.).

Results were negative yet again. No target genes were selected by the Pax7d-vector
fusion protein (Figure 4.14. Lane, +). Moreover, as expeated no PCR products were
visible for samples isolated from transfected cells but without immunoprecipitation (no
antibody control) (Figure 4.14. Lane, -). In contrast, products of expected sizes were
visible for input chromatin (untransfected P19 cells) that were not precleared,
immunoprecipitated, washed or eluted (Figure 4.14. Lane, I). No products were visible
for blank samples that consisted of all PCR reaction components minus template DNA
(Figure 4.14. Lane, B).
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B I - +

CntfR

bp

Eya4
Gbxl
Rasa3 ~601 bp
Kcnk2 ~725 bp
Prrxl ~470 bp
Figure 4.14. ChiP-PCR for target gene selection by Pax7d-vector fusion protein
immunoprecipitated with the V5 antibody: (Left-right) (B) blank PCR samples
consisting of all PCR reaction constituents minus template DNA, no products are visible.
(I) Input samples showing visible products of target genes of expected sizes (Top-bottom)
CntfR, 593 bp; Eya4, 775 bp; Gbxl, 378 bp; Rasa3, 601 bp; Kcnk2, 725 bp, and Prrxl,
470 bp. (-) No antibody controls amplified with target gene primer pairs (Table 3.1.)
(Top-bottom) CntfR, Eya4, Gbxl, Rasa3, Kcnk2 and Prrxl. For all target genes, no PCR
products are visible. (+) Pax7d isoform immunoprecipitated with V5 antibody and
amplified with target gene primer pairs (Top-bottom) CntfR, Eya4, Gbxl, Rasa3, Kcnk2
and Prrxl, no products are visible.
Results indicate that using the ChiP procedure pefotmed here, no DNA from the genes
was present in the immunoprecipitated samples, since there are no visible PCR products
for target genes chosen for investigation. In contrast, input chromatin (untransfected P 19
cells not immunoprecipitated) amplified each target gene (Figure 4.14. Lane, I).

Attempts to immunoprecipitate Pax7-vector-DNA complexes with the Pax7 antibody
were not possible without agarose G beads which were not available in our laboratory at
the time.

4.12. Target gene regulation by Pax7d
Since we were not able to identify target genes bound by Pax7 using the ChiP
procedure, Pax7d transfected cells were analysed for differential regulation of target
genes relative to untransfected cells.

4.12.1. mRNA expression of each target gene
P19 cells stably transfected with the Pax7d-vector construct were propagated to analyze
the regulation of target genes CnftR, Gbxl, Rasa3, Eya4 and Kcnk2 by RT-PCR. The
regulation of target genes by the Pax7d isoform in stably transfected P19 cells was
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assessed by RT -PCR after treatment with DNase 1 (to remove transfected DNA). Target
genes were amplified utilizing primer pairs corresponding to the exonic sequences in
each of the genes (Table 4.1.). RT-PCR products at expected sizes of 274 bp and 162 bp
were obtained for CnifR and Rasa3 target genes respectively (Figure 4.15. CnifR and

Rasa3, Lanes+). In contrast, no products were visible for all other target genes for cells
either transfected or untransfected with the Pax7d-vector construct (Figure 4.15. Eya4,

Gbxl and Kcnk2 Lanes, + and C for each target gene respectively). No product was
obtained for the blank sample containing all PCR reaction constituents minus template
DNA (Figure 4.15. Lanes labelled B).

Table 4.1. Primer sequences, PCR annealing temperatures and expected sizes of
PCR products analysed by RT -PCR analysis.
Gene

Primer sequences

Amplicon
size (bp)

CnifR

F:5'-ACACGCAGAAACACAGTCCAC-3'

274

R:5'-TTGGAGCGGCAGCTGAGCAC-3'

Eya4

F:5'-GTAAAGAAAACGTGCCCAG-3'

258

R:5'-AAAAGTGTCAAGCGCTCC-3'

Gbxl

F:5'-ACGCTGAGGAGCTGCTGC-3'

163

R:5'-TCGCTGCCTGCTGGGTCTC-3'

Rasa3

F:5'-AGGGACACATGGTTCCAGC-3'

162

R:5'-GTTCACAATGGGGAGACC-3'

Kcnk2

F:5'-TCAAGTTAGTCACTGGGAC-3'
R:5'-ATGTGTCTTCCACTTTGGC-3'
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Kcnk2

Gbx1

Cntfr

Figure 4.15. RT -PCR products indicating regulation of target genes in P19 cells
stably transfected with the Pax7d-vector construct: (Left to right) + Lanes (Rasa3,)
and (CntjR) generated PCR products of expected sizes 162 bp and 274 bp respectively.
Results from Pax7-vector transfected Pl9 cells were compared to untransfected P19 cells
where no PCR products are visible for target genes CntjR, Eya4, Gbxl, Rasa3 and Kcnk2
(Lanes labeled C). No products are visible in the blank samples (Lanes labelled B),
consisting of all PCR reaction constituents minus the template DNA. Lane M, lkb plus
DNA ladder.
RT -PCR results confirm that only the target genes CntjR and Rasa3 were successfully
up-regulated in P19 cells stably transfected with the Pax7d-vector construct.
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Chapter 5

5.1

DISCUSSION
Introduction

Previous knockout and transfection studies have revealed the importance of Pax7 for
nervous and muscular system development (Seale et al., 1999; Mansouri et al., 1994;
Jostes et al., 1990). The role of Pax7 within both myogenic and neurogenic lineages
signifies the diverse biological functions of Pax7, which may be explained by the
presence of structurally distinct Pax7 isoforms. These isoforms differ in the structure of
their DNA-binding domain (paired domain) known to influence target gene selection
(Schafer et al., 1994), and are hypothesized to account for the diverse functions of Pax7.
Although the transcripts encoding these isoforms are present in both neurogenic and
myogenic cell lines (Ziman and Kay, 1998; Ziman et al., 1997), the functional
significance of each Pax7 isoform for specification of these cell types remains unknown.

It was envisaged that this present study would be one of the first to identify the DNA-

binding differences between each Pax7a-d isoform in terms of selecting specific target
genes thereby characterizing each Pax7 isoform's specific role within a cell. This
research is necessary since functionally-specific Pax7 isoforms are possible candidates
for use in future stem cell/ gene therapy approaches.

5.2.

Upregulation of Cnt.fR and Rasa3 target genes by the Pax7d transcript

Pax7 is kl1own to be involved in neural sub-type specification in the midbrain and in

specification of skeletal muscle satellite cells (Seale et al., 1999; Jostes et al., 1990). A
previous study has delineated the role of Pax7 further by identification of several
downstream target genes (White and Ziman, 2006). Here we provide the first evidence
confirming a link between Pax7 and upregulation of CntfR and Rasa3. The present study
shows that transfection ofthe Pax7dtranscript into P19 cells, causes the upregulation of
CntfR and Rasa3 target genes.

CntfR plays a critical role in the developing and mature central nervous system (Ip et al.,

1993) and has a functional role in the degeneration and regeneration ofmyofibers during
muscle repair and regeneration (Marques and Neto, 1997). Research has shown that the
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ligand for CntjR, CNTF is predominantly expressed by glial cells (Stockli et al,. 1989)
and schwann cells of peripheral motor neurons and in astrocytes in the central nervous
sytem (Stockli et al., 1989). CNTF exerts functional effects from schwann cells (Ip et al.,
1993; Sendtner et al., 1992) and has been shown to cause neuronal growth and
cholinergic formation, as well as stimulate choline acetyltransferase and the production of
acetylcholine in specific neuroblastoma cell lines (Kirsch et al., 1997; Kirsch et al., 1996;
Fuhrmann et al., 1995; Meyer-Franke et al., 1995; LaVail et al., 1992; Ernsberger et al.;
i989; Lehwalder et al., 1989; Hofinann, 1988).

Furthermore, CNTF has been implicated in determination of the cell fate of neural stem
cells, proliferation of neuronal precursor cells and the survival and differentiation of a
variety of neurons in the peripheral and central nervous systems (Bonni et al., 1997; Ip
and Yancopoulos, 1996; Ip et al., 1994; Patterson, 1994; Sendtner et al., 1994). The
protein acts in response to spinal cord and striatal injuries (Lee et al., 1998; Oyesiku et
al., 1996; Asada et al., 1995), hippocampal deafferentation (Guthrie et al., 1997) and
ischemia (Park et al., 2000).

An in vivo study has shown that exogenous application of CNTF to rejuvenating muscle
increases myotube formation (Marques and Neto, 1997) and that CNTF expression
increases in response to denervation of muscles (Helgren et al., 1994; Ip et al., 1993).
Furthermore, research has found that a mutation in the CntjR gene in mice induced severe
motor neuron defects (DeChiara et al., 1995), confirming that CNTFR plays a critical role
in nervous system development. In view of the importance of CntjR and its ligand in
muscle and nerve development, specification and regeneration and the diverse functional
roles ascribed to Pax7, the emerging scenario suggests that the Pax7d transcript may
induce neural and myogenic specification via regulation of CntjR.

The suggestion that the Pax7d transcript is important for both neural and myogenic
development is further supported by previous studies on alternate Pax7 transcripts which
detail dominant Pax7d expression in the neurogenic cell line (Ziman and Kay, 1998;
Ziman et al., 1997) but when transfected into haematopoetic stem cells Pax7d causes
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myogenic differentiation (Seale et al., 2004). The results presented here confirm a role for
Pax7 in these processes, possibly via upregulation of CntjR.

Additionally, the target gene Rasa3 plays an important role in cell signalling and cellular
transformation. Previous studies have suggested a crucial role for the gene in cell survival
signalled by nerve growth factors in sympathetic neurons (Nobes et al., 1996). In view of
the functional roles ascribed to both Rasa3 and Pax7, the results from the present study
indicate that the role of Pax7d in specification of cells during neural development may be
mediated by Rasa3.

The Pax7dtranscript excludes the hexanucleotide sequence (GTTTAG) within its mRNA
structure (Ziman et al., 2001). Interestingly, the finding that Pax7 transcripts excluding
the hexanucleotide sequence in ascidians (Halocynthia roretzi), resulted in the formation
of neural structures (Wada et al., 1997) adding further support for a neural function for

Pax7d.

Due to time constraints, further studies on cells transfected with Pax7a, Pax7b and Pax7c
were not completed and thus determination of target genes selected by individual
transcripts could not be determined. However, several important advances on ChiP
method~ logy

5.3.

were made as a result of this research project.

Appropriateness of the chromatin immunoprecipitation technique

Immunoprecipitation of epitope-tagged Pax7-isoform-DNA complexes is a highly
specific and complex procedure and was a suitable technique with which to investigate
the DNA-binding differences between each Pax7 isoform. By using immunoprecipitation
of transfected epitope-tagged isoforms bound to target genes it should have been possible
to determine the selected target genes bound by each Pax7 isoform (separately from these
bound by multiple endogenous Pax7 isoforms). This was an important consideration
since, a single Pax7d transcript infected into haematopoetic stem cells upregulated
endogenous Pax7 transcripts (Seale et al., 2004). However in transfection studies
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conducted for this project, endogenous Pax7 did not appear to be upregulated, (as judged
by a single band obtained by western blot utilizing a Pax7-specific antibody).

Chromatin immunoprecipitation encompasses four experimental components including
an initial fixation step, followed by sonication, immunoprecipitation and finally an
analysis ofthe immunoprecipitated DNA. Das and colleagues (2004) reinforce that it is a
complicated procedure, requiring optimization of reaction conditions, an obstacle faced in
this present study.

In this study, NIH3T3 cells stably transfected with each Pax7 transcript were subjected to
the first few stages of chromatin immunoprecipitation involving formaldehyde
crosslinking, sonication and lysing of nuclei. Western blot procedures were then
conducted to confirm the level of Pax7 isoform expression before proceeding with ChiP:
Since positive Pax7 fusion protein was observed for the Pax7c isoform (Figure 4.4.A.)
these cells were subjected to the remainder of ChiP. I:Iowever, whilst ChiP was
performed on the Pax7c isoform, trials were simultaneously conducted on untransfected
NIH3T3 cells to obtain optimal DNA shearing conditions~ only to discover that DNA was
being lost somewhere within the procedure.

The maintenance of DNA quantity throughout the ChiP procedure is vital since the loss
of DNA minimizes the possibility of obtaining meaningful results from the overall
investigation. In the experiments conducted here, it is possible that no DNA was present
when Pax7-isoform-DNA complexes were immunoprecipitated from the NIH3T3
genome due to DNA losses and as a result the final PCR product revealed a negative
result for the selection of target genes.

A large amount of time was spent minimizing the amount of DNA lost during the
procedure. Method optimization was conducted with untransfected NIH3T3 cells, and
several different methods of cell collection were assessed. Results suggested that direct
application of nuclear lysis buffer to cells resulted in greater DNA recovery compared to
other methods of cell collection after formaldehyde crosslinking. It is therefore possible
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to conclude that in the first ChiP experiment, loss of DNA due to accutased cell
collection, was responsible for unsuccessful collection of the maximum number of cells,
subsequently decreasing immunoprecipitation efficiency during ChiP. DNA purification
after immunoprecipitation by DNA purification kit rather than by phenol chloroform
isoamyl extraction caused further DNA losses.

5.4

Optimization of transfections

While ChiP studies conducted on Pax7(a-d) transfected cells were not successful, it
would not be credible to conclude that the Pax7c isoform does not bind to these target
genes since numerous possibilities can account for the negative result. The loss of DNA
during the ChiP procedure is a major factor contributing to lack of positive results.
Another major contributing factor to the negative outcome was the low transfection
efficiency. Not enough cells expressed the Pax7c isoform to

give results;

immunocytochemistry revealed that only 1: 100 cells were relatively expressing the Pax7
isoform.

It is critical for all stably transfected cells to express Pax7 isoforms to ensure that enough
protein is present in cells to be bound at any one time to DNA during formaldehyde
crosslinking procedures. Cross linking of Pax7 to DNA targets would essentially freeze 'a
moment in time' when a number of Pax7 molecules would be expected to be bound to
different target genes. To identify these target genes bound at any one moment requires
that a large amount of Pax7 be bound to the target genes at that moment for positive
identification by ChiP. Therefore, insufficient Pax7 levels at any one time may have
resulted in the levels of target genes selected being too low to be detected by ChiP.

Most ChiP studies are conducted on whole tissue (Antonini et al., 2006; Jelinic et al.,
2006; Matsukuma et al., 2006; Plateroti et al., 2006; Pedchenko et al., 2005; Peng and
Chen, 2005; Pierreux et al., 2004) or embryos (Terranova et al., 2006; White and Ziman,
2006; Magness et al., 2004; Jasinskiene et al., 1995) where there are large numbers of
cells containing transcription factors bound to specific target genes at any one moment in
time.
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However, other studies have subjected transiently transfected cells to chromatin
immunoprecipitation and have obtained conclusive results (Agbottah et al., 2006; Esumi
et al., 2006; Gong et al., 2006; Valineva et al., 2006). In these previous studies stable
transfections were used and the multi-step procedures of ChiP were modified relative to
our own study. For example one such study conducted formaldehyde crosslinking for a
longer period of time (Gong et al., 2006). In effect, this may result in greater preservation
of already bound proteins for subsequent coarse steps of the ChiP procedure for positive
identification

by

ChiP.

These

results

suggest

that

perhaps

the

chromatin

immunoprecipitation technique was not sufficiently optimized to produce a conclusive
result in our own study.

While the limited amount of cells expressing the isoform in the nucleus w:;ts a major
reason for negative results in the first ChiP experiment, in the second experiment when a
Pax7d stably transfected cell line was utilized and more cells were expressing the isoform

in the nucleus, ChiP-PCR results still displayed no target gene selection after DNA
purification. Since many of the methodological errors from the initial experimental
attempt were resolved, it may be possible to conclude that the Pax7d isoform does not
bind to Eya4, Gbxl, KcnK2 and Prrxl target genes in vitro. However, since RT-PCR
results of the Pax7d transfected P19 cells show that the target genes CntjR and Rasa3
were up-regulated by Pax7d, it is not credible to conclude that the isoform does not bind
to these target genes. The only other possible explanations are that either Pax7d does not
bind directly to target genes CntjR and Rasa3 to upregulate their expression or that the
chromatin immunoprecipitation procedure was inadequate for analyzing Pax7 isoform
DNA-binding differences in transfected cell lines. Moreover, since Pax7 has diverse
functional roles in both neurogenic and myogenic cell lines (Ziman and Kay, 1998;
Ziman et al., 1997), it is possible that the Pax7 protein binds to different target genes in
different cell lines, or that the Pax7 protein is unable to bind to different target genes
simultaneously.

Alternately, perhaps the wrong set of genes were chosen for investigation. The choice of
target genes for another testing is an important consideration. The immunoprecipitated
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DNA is possible to assess by promoter-specific PCR for a genuine target (Wang et al.,
2002; Boyd and Farnham, 1999). However, while we checked several of the identified
target genes of Pax7 (White and Ziman, 2006), it was not possible to check them all in
the short time available.

5.5.

Implications for no target gene selection byPax7d

5.5.1. Pax7d protein structure and DNA-binding function
It is known that all Pax7 isoforms differ in the structure of their DNA-binding domain
(paired domain) which influences the selection of downstream target genes. The Pax7d
isoform includes a trinucleotide sequence (CAG) that encodes the amino acid residue
glutamine (Q+) within the linker region between the P AI and RED subdomains of the
paired domain (Figure 5.l.a.).

Previous studies have noted that a single glutamine residue within the paired domain
causes only the PAl subdomain to bind to DNA (Duet al., 2005; Vogan and Gros, 1997;
Vogan et al., 1996) (Figure 5.l.b.). Although the third alpha helix present within each
subdomain is the principle component allowing each subdomain to interact with DNA
(Figure 5.l.b.) (Kay and Ziman, 1999; Ziman and Kay, 1998; Balczarek et al., 1997;
Vogan et al., 1996; Treisman et al., 1991), research has shown that a single glutamine
(Q+) within the linker region extends the length of this linker region, which inhibits
binding of the RED domain to target genes (Xu et al., 1999; Fortin et al., 1998; Jun et al.,
1998; Vogan and Gros, 1997; Vogan et al., 1996). In effect, the structural alteration may
restrict the DNA-binding potential of the Pax7 protein to target genes. It is possible that
such a structural alteration resulted in no target gene selection by Pax7d.

Furthermore, research has shown that Pax proteins are capable of utilizing the paired
domain in combination with the homeodomain to recognize specific DNA sequences, and
thus influence target gene selection (Xu et al, 1999; Jun et al, 1998; Kozmik et al, 1997;
Underhill and Gros, 1997; Vogan and Gros, 1997; Jun and Desplan, 1996; Miskiewicz et
al, 1996; Xu et al, 1995) (Figure 5.l.b.). Therefore, it is possible that interactions between
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the PAl subdomain region and the homeodomain may have restricted Pax7d DNAbinding ability resulting in limited target gene selection.

a.
Paired domain

Octapeptide

"--____a_+___

Homeodomain

GL- _ _ _ _ _ _ ____/

--v-

P8X7d
(Q+,GL-)

Figure 5.1.a. Pax7d isoform structure: The Pax7d isoform consists of a paired domain,
comprising two subdomains (PAI) and (RED) that are each composed of three alpha
helices (numbered). The isoform Pax7d includes the amino acid residue glutamine (Q+)
between the PAl and RED subdomains but excludes amino acids glycine and leucine
(GL-) within the RED subdomain. The octapeptide is located between the paired domain
and homeodomain. The homeodomain contains three alpha helices (numbered) (Ziman
and White, 2006).

Figure 5.1.b. Pax7d interacting with DNA: The
Pax7d isoform includes the amino acid residue
glutamine {Q+). This isoform only utilizes the
(PAI) subdomain to bind to DNA influencing
target gene selection. The third alpha helices (red)
allow
subdomain-DNA
interaction.
The
Homeodomain (HD) is known to function in
combination with the paired domain to influence
target gene selection (Du et al., 2005; Chi and
Epstein, 2002).
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Additonally, previous studies have shown that the transactivation domain interacts with
other transcription factors and the proteins of the general transcriptional machinery to
activate transcription of target genes (Ziman and White, 2006; Hadchouel et al., 2003;
Schafer et al., 1994). Interestingly, it is possible that the epitope tag fused to the Pax7
protein may have blocked interactions of the transactivation domain with other proteins,
restricting the activation of target genes, and thus limiting target gene selection.

5.5.2. Other factors affecting Pax7d DNA-binding
Interestingly, multiple transcription factors and interacting proteins present in particular
cell types have the potential to significantly affect the DNA-binding capacity of
transcription factors (Chakrabarti et al., 2002; Qiu et al., 2002; Dutta et al., 2001; Glick et
al., 2000; Ohneda et al., 2000; Peers et al., 1994). Results from this thesis show that the
Pax7 d isoform did not select target genes Eya4, Gbxl, Kcnk2 and Prrxl, in vitro, whereas
these genes were identified as Pax7 target genes in vivo, s.uggesting that several other
transcription factor proteins not present in P19 cells are required to interact with Pax7d to
facilitate binding to the target gene.

Additionally, previous studies have shown that the nuclear chromatin environment affects
the binding of transcription factors to promoter sites (Chakrabarti et al., 2002; Spencer et
al., 1999; Grunstein, 1997). It is possible that in this study the use of cell lines NIH3T3
and P19 with different chromatin structure to cells in vivo may have affected Pax7d
DNA-binding ability in vitro relative to binding in vivo (Chakrabarti et al., 2002; Qiu et
al., 2002; Dutta et al., 2001; Glick et al., 2000; Ohneda et al., 2000; Peers et al., 1994).

Furthermore, it is possible that all isoforms of Pax7 are required to function iri
combination to select target genes. Evidence on the combined function of Pax7 isoforms
remains to be determined. Alternatively, the possibility exists that Pax7d only binds to

CntfR and Rasa3, a result thought possible sinde only CntfR and Rasa3 were noticeably
upregulated in Pax7d transfected cells. It is not possible to comment on the ability of
Pax7 to bind to other genes since no change in their gene expression levels was noted in
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transfected cells. It remains possible that Pax7 bound to selected target genes to inhibit
their expression in vitro as these genes were not up regulated in P 19 cells and thus
inhibition of their expression after Pax7 transfection could not be assessed.

5.5.3. Utilization of chromatin immunoprecipitation for target gene selection in
vivo and in vitro
Many studies have obtained remarkable findings that have expanded knowledge and
understanding of protein-DNA interactions within mammalian cells or tissues by
utilization of the chromatin immunoprecipitation technique. However, in the majority of
studies, the technique is frequently applied to embryonic tissue as opposed to cell lines
(Antonini et al,. 2006; Jelinic et al,. 2006; Matsukuma et al,. 2006; Mayanil et al,. 2006;
Plateroti et al,. 2006; Terranova et al,. 2006; White and Ziman, 2006; Pedchenko et al,.
2005; Peng and Chen,. 2005; Magness et al,. 2004; Pierreux et al., 2004; Jasinskiene et
al., 1995). For example, Mayanil and colleagues (2006), applied the chromatin
immunoprecipitation technique to E10.0 Pax3+!+ moustt embryos utilizing rabbit
polyclonal Pax3 antibody to investigate the regulation of a specific target gene by Pax3
during early embryonic development. Furthermore, Peng and Chen (2005), utilized
photoreceptor transcription factors Crx, Otx2, Nrl and Nr2e3 to investigate binding of
these proteins to promoter sites of photoreceptor genes in the retina of wild type and
mutant mice. Both investigations performed PCR analysis with designed primer sets, and
obtained conclusive results. These studies suggest that chromatin immunoprecipitation is
better suited for in vivo studies in embryonic or adult tissue.

A previous chromatin immunoprecipitation study showed that Pax7 target genes CntjR,

Eya4, Gbxl, Rasa3, KcnK2 and Prrxl are bound by the Pax7 protein in developing
mouse embryos (White and Ziman, 2006). In this project, while both mouse NIH3T3 and
P19 embryonal cells were utilized to observe Pax7 isoform DNA-binding in vitro, no
conclusive results were obtained. Therefore, the possibility/exists that target genes bound
by a transcription factor in vivo may not be bound by the same genes in vitro. The
suggestion is supported by a study conducted with several Drosophila transcription
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factors known to bind to target genes in vivo whereas these same genes were not bound in

vitro (Carr and Biggin, 1999; Walter and Biggin, 1996).

5.6.

Advantages and disadvantages of chromatin immunoprecipitation

According to Peng and Chen (2005), chromatin iinmunoprecipitation technology has
numerous advantages over other methodologies for studying protein-DNA interactions in

vivo and in vitro, however there are limitations to utilization of the method.

Chromatin immunoprecipitation is a novel methodology used to investigate specific
protein-DNA interactions in vivo (Peng and Chen, 2005). The technique provides binding
profiles for an array of transcription factors. However, only DNA sequences directly
bound by a given transcription factor at any one time within a living cell can be identified
(Weinmann and Farnham, 2002). This strengthens the possibility that the Pax7d isoform
interacts with other factors to upregulate CntjR and Rasa3 but does not bind directly to
the target genes under investigation and thus may explain. why no target genes were
selected by ChiP.

5.7

SUMMARY

Pax7, CntjR and Rasa3 all perform important functional roles in nervous system and or
skeletal muscle development. The direct or indirect upregulation of CntjR and Rasa3 by

Pax7d remains to be determined. However, from results presented in this thesis, the role
of Pax7d in neural and myogenic functions is strengthened, and adds weight to previous
experiments which merely detail expression of Pax7d in neurogenic and myogenic
lineages.

The Pax7d isoform did not appear to bind directly to target genes CntjR, Eya4, Gbxl,

Rasa3, Kcnk2 and Prrxl in vitro. Several reasons for this have been identified; it is
possible that the Pax7d isoform structure and DNA-binding ability do not allow direct
interaction with the selected target genes, whereas it may bind to many other genes not
identified here. However, the possibility that all Pax7 isoforms are necessary for target
gene selection requires further investigation.
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Other possibilities for the negative results are associated with the methodology and the
use of in vitro cell lines. Perhaps the chromatin immunoprecipitation technique is not
effective when applied to a stably transfected cell line, as previous studies have applied
the technique to embryonic tissues and transiently transfected cells. DNA-binding
abilities of a given transcription factor in vitro are significantly affected by the chromatin
structure of the cell type utilized and the presence of interacting proteins. Further
optimization of the method may provide results in the future.

Studies on the binding affinities and specificity of each alternate isoform are impmiant
and would provide a clearer understanding of the specific roles of each isoform within a
cell and would expand the diverse functions ascribed to the Paxl gene.

75

CHAPTER SIX

CONCLUDING
COMMENTS

Chapter Six: Concluding comments

Chapter 6

CONCLUDING COMMENTS

From the results presented in this thesis it can be concluded that the Pax7d transcript is
important for both neural and myogenic function. This is supported by research that has
shown predominant Pax7d expression in a neurogenic lineage and that transfection of the
transcript into haematopoetic stem cells induced myogenic differentiation. The Pax7d
transcript encoding the Pax7d isoform was not shown to be bound directly to target genes

CntjR, Eya4, Gbxl, Rasa3, Kcnk2 and Prrxl in vitro. No target gene selection may be
attributed to the incorrect choice of target genes, the Pax7d isoform structure and DNAbinding function, interactions between the paired domain, homeodomain and epitope tag
interfering with Pax7d DNA-binding, and the ineffective application of the chromatin
itnmunoprecipitation technique in cell lines (given that DNA-binding is affected by
chromatin structure environment and the presence of interacting proteins).

Moreover, the possibility that Pax7 isoforms function in combination to bind to DNA
I

requires further investigation. Further investigation on the DNA-binding differences
between each Pax7 isoform are necessary to provide much needed answers for the overall
function of the Pax7 gene.
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Appendix 1: Pax7 alternate transcript inserts cloned into the pcDNA3.1D/V5-HisTOPO expression vector

Pax7a -/+cloned region:
GACTCTGGATTCGTCTCCAGCGTGTGCAGAAATGGCGGCGCTGCCCGGCGCGGTCCCCAGGATGATGAGA
CCCGGCCCGGGGCAGAACTACCCGCGCACCGGCTTCCCCCTGGAAGTGTCCACCCCTCTTGGCCAAGGCC
GGGTCAATCAGCTTGGTGGGGTCTTCATCAATGGTCGACCCCTGCCGAACCACATCCGTCACAAGATAGT
GGAAATGGCCCACCATGGCATCCGGCCCTGCGTCATCTCCCGTCAGCTCCGTGTTTCTCATGGTTGTGTC
TCCAAGATTCTGTGCCGATATCAGGAGACTGGGTCCATCCGGCCCGGGGCTATCGGAGGCAGCAAGCCCA
GAGTGGCGACTCCGGATGTGGAGAAAAAGATTGAGGAGTATAAGAGAGAGAACCCCGGGATGTTCAGCTG
GGAAATCCGGGACCGGCTGCTGAAGGACGGTCACTGCGACCGAAGCACGGTGCCCTCAGGTTTAGTGAGT
TCGATTAGCCGAGTGCTCAGAATCAAGTTCGGGAAGAAAGAGGACGACGAGGAAGGAGACAAGAAAGAAG
AAGATGGCGAGAAGAAAGCCAAACACAGCATCGATGGCATCCTGGGCGACAAAGGGAACCGTCTGGATGA
GGGCTCAGATGTGGAATCAGAACCCGACCTCCCCCTGAAGCGCAAGCAGCGCCGCAGTCGGACCACGTTC
ACAGCCGAGCAGCTGGAGGAGCTAGAGAAGGCCTTTGAGAGGACCCACTACCCGGACATCTACACCCGGG
AGGAGCTGGCACAGAGGACCAAGCTCACGGAGGCACGCGTCCAGGTCTGGTTCAGTAACCGGCGTGCCCG
CTGGCGCAAGCAGGCAGGAGCTAACCAGCTGGCCGCCTTCAACCACCTTCTGCCGGGAGGTTTCCCACCC
ACCGGCATGCCCACGCTGCCACCCTACCAGCTGCCGGACTCTACCTACCCCACCACCACCATCTCCCAAG
ATGGGGGCAGCACAGTACACAGGCCCCAGCCCCTTCCGCCATCAACCATGCATCAGGGTGGGCTGGCTGC
GGCCGCTGCAGCAGCAGACACCAGCTCTGCCTACGGAGCCCGCCACAGCTTCTCCAGCTACTCTGACAGC
TTCATGAACCCTGGGGCTCCCTCCAACCACATGAACCCTGTCAGCAATGGCCTGTCTCCTCAGGTCATGA
GCATCCTTAGCAACCCGAGTGCCGTGCCTCCACAGCCCCAGGCCGACTTCTCCATCTCCCCGCTGCATGG
AGGCCTGGACTCGGCTTCCTCCATCTCAGCCAGCTGCAGCCAACGGGCCGACTCCATCAAGCCAGGAGAC
AGCTTGCCCACGTCCCAGTCTTACTGCCCACCCACCTACAGCACCACTGGCTACAGTGTGGACCCTGTGG
CTGGCTACCAGTACAGCCAGTATGGCCAAACTGCTGTTGATTACCTGGCCAAAAACGTGAGCCTGTCCAC
ACAGCGCCGTATGAAGCTTGGGGAACACTCCGCTGTGCTGGGACTTCTTCCTGTGGAAACGGGACAAGCC
TAC
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Pax7b +/+ cloned region:
GACTCTGGATTCGTCTCCAGCGTGTGCAGAAATGGCGGCGCTGCCCGGCGCGGTCCCCAGGATGATGAGA
CCCGGCCCGGGGCAGAACTACCCGCGCACCGGCTTCCCCCTGGAAGTGTCCACCCCTCTTGGCCAAGGCC
GGGTCAATCAGCTTGGTGGGGTCTTCATCAATGGTCGACCCCTGCCGAACCACATCCGTCACAAGATAGT
GGAAATGGCCCACCATGGCATCCGGCCCTGCGTCATCTCCCGTCAGCTCCGTGTTTCTCATGGTTGTGTC
TCCAAGATTCTGTGCCGATATCAGGAGACTGGGTCCATCCGGCCCGGGGCTATCGGAGGCAGCAAGCCCA
GACAGGTGGCGACTCCGGATGTGGAGAAAAAGATTGAGGAGTATAAGAGAGAGAACCCCGGGATGTTCAG
CTGGGAAATCCGGGACCGGCTGCTGAAGGACGGTCACTGCGACCGAAGCACGGTGCCCTCAGGTTTAGTG
AGTTCGATTAGCCGAGTGCTCAGAATCAAGTTCGGGAAGAAAGAGGACGACGAGGAAGGAGACAAGAAAG
AAGAAGATGGCGAGAAGAAAGCCAAACACAGCATCGATGGCATCCTGGGCGACAAAGGGAACCGTCTGGA
TGAGGGCTCAGATGTGGAATCAGAACCCGACCTCCCCCTGAAGCGCAAGCAGCGCCGCAGTCGGACCACG
TTCACAGCCGAGCAGCTGGAGGAGCTAGAGAAGGCCTTTGAGAGGACCCACTACCCGGACATCTACACCC
GGGAGGAGCTGGCACAGAGGACCAAGCTCACGGAGGCACGCGTCCAGGTCTGGTTCAGTAACCGGCGTGC
CCGCTGGCGCAAGCAGGCAGGAGCTAACCAGCTGGCCGCCTTCAACCACCTTCTGCCGGGAGGTTTCCCA
CCCACCGGCATGCCCACGCTGCCACCCTACCAGCTGCCGGACTCTACCTACCCCACCACCACCATCTCCC
AAGATGGGGGCAGCACAGTACACAGGCCCCAGCCCCTTCCGCCATCAACCATGCATCAGGGTGGGCTGGC
TGCGGCCGCTGCAGCAGCAGACACCAGCTCTGCCTACGGAGCCCGCCACAGCTTCTCCAGCTACTCTGAC
AGCTTCATGAACCCTGGGGCTCCCTCCAACCACATGAACCCTGTCAGCAATGGCCTGTCTCCTCAGGTCA
TGAGCATCCTTAGCAACCCGAGTGCCGTGCCTCCACAGCCCCAGGCCGACTTCTCCATCTCCCCGCTGCA
TGGAGGCCTGGACTCGGCTTCCTCCATCTCAGCCAGCTGCAGCCAACGGGCCGACTCCATCAAGCCAGGA
GACAGCTTGCCCACGTCCCAGTCTTACTGCCCACCCACCTACAGCACCACTGGCTACAGTGTGGACCCTG
TGGCTGGCTACCAGTACAGCCAGTATGGCCAAACTGCTGTTGATTACCTGGCCAAAAACGTGAGCCTGTC
CACACAGCGCCGTATGAAGCTTGGGGAACACTCCGCTGTGCTGGGACTTCTTCCTGTGGAAACGGGACAA
GCCTAC
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Pax7c -/-cloned region:
GACTCTGGATTCGTCTCCAGCGTGTGCAGAAATGGCGGCGCTGCCCGGCGCGGTCCCCAGGATGATGAGA
CCCGGCCCGGGGCAGAACTACCCGCGCACCGGCTTCCCCCTGGAAGTGTCCACCCCTCTTGGCCAAGGCC
GGGTCAATCAGCTTGGTGGGGTCTTCATCAATGGTCGACCCCTGCCGAACCACATCCGTCACAAGATAGT
GGAAATGGCCCACCATGGCATCCGGCCCTGCGTCATCTCCCGTCAGCTCCGTGTTTCTCATGGTTGTGTC
TCCAAGATTCTGTGCCGATATCAGGAGACTGGGTCCATCCGGCCCGGGGCTATCGGAGGCAGCAAGCCCA
GAGTGGCGACTCCGGATGTGGAGAAAAAGATTGAGGAGTATAAGAGAGAGAACCCCGGGATGTTCAGCTG
GGAAATCCGGGACCGGCTGCTGAAGGACGGTCACTGCGACCGAAGCACGGTGCCCTCAGTGAGTTCGATT
AGCCGAGTGCTCAGAATCAAGTTCGGGAAGAAAGAGGACGACGAGGAAGGAGACAAGAAAGAAGAAGATG
GCGAGAAGAAAGCCAAACACAGCATCGATGGCATCCTGGGCGACAAAGGGAACCGTCTGGATGAGGGCTC
AGATGTGGAATCAGAACCCGACCTCCCCCTGAAGCGCAAGCAGCGCCGCAGTCGGACCACGTTCACAGCC
GAGCAGCTGGAGGAGCTAGAGAAGGCCTTTGAGAGGACCCACTACCCGGACATCTACACCCGGGAGGAGC
TGGCACAGAGGACCAAGCTCACGGAGGCACGCGTCCAGGTCTGGTTCAGTAACCGGCGTGCCCGCTGGCG
CAAGCAGGCAGGAGCTAACCAGCTGGCCGCCTTCAACCACCTTCTGCCGGGAGGTTTCCCACCCACCGGC
ATGCCCACGCTGCCACCCTACCAGCTGCCGGACTCTACCTACCCCACCACCACCATCTCCCAAGATGGGG
GCAGCACAGTACACAGGCCCCAGCCCCTTCCGCCATCAACCATGCATCAGGGTGGGCTGGCTGCGGCCGC
TGCAGCAGCAGACACCAGCTCTGCCTACGGAGCCCGCCACAGCTTCTCCAGCTACTCTGACAGCTTCATG
AACCCTGGGGCTCCCTCCAACCACATGAACCCTGTCAGCAATGGCCTGTCTCCTCAGGTCATGAGCATCC
TTAGCAACCCGAGTGCCGTGCCTCCACAGCCCCAGGCCGACTTCTCCATCTCCCCGCTGCATGGAGGCCT
GGACTCGGCTTCCTCCATCTCAGCCAGCTGCAGCCAACGGGCCGACTCCATCAAGCCAGGAGACAGCTTG
CCCACGTCCCAGTCTTACTGCCCACCCACCTACAGCACCACTGGCTACAGTGTGGACCCTGTGGCTGGCT
ACCAGTACAGCCAGTATGGCCAAACTGCTGTTGATTACCTGGCCAAAAACGTGAGCCTGTCCACACAGCG
CCGTATGAAGCTTGGGGAACACTCCGCTGTGCTGGGACTTCTTCCTGTGGAAACGGGACAAGCCTAC
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Pax7d +/-cloned region:
GACTCTGGATTCGTCTCCAGCGTGTGCAGAAATGGCGGCGCTGCCCGGCGCGGTCCCCAGGATGATGAGA
CCCGGCCCGGGGCAGAACTACCCGCGCACCGGCTTCCCCCTGGAAGTGTCCACCCCTCTTGGCCAAGGCC
GGGTCAATCAGCTTGGTGGGGTCTTCATCAATGGTCGACCCCTGCCGAACCACATCCGTCACAAGATAGT
GGAAATGGCCCACCATGGCATCCGGCCCTGCGTCATCTCCCGTCAGCTCCGTGTTTCTCATGGTTGTGTC
TCCAAGATTCTGTGCCGATATCAGGAGACTGGGTCCATCCGGCCCGGGGCTATCGGAGGCAGCAAGCCCA
GACAGGTGGCGACTCCGGATGTGGAGAAAAAGATTGAGGAGTATAAGAGAGAGAACCCCGGGATGTTCAG
CTGGGAAATCCGGGACCGGCTGCTGAAGGACGGTCACTGCGACCGAAGCACGGTGCCCTCAGTGAGTTCG
ATTAGCCGAGTGCTCAGAATCAAGTTCGGGAAGAAAGAGGACGACGAGGAAGGAGACAAGAAAGAAGAAG
ATGGCGAGAAGAAAGCCAAACACAGCATCGATGGCATCCTGGGCGACAAAGGGAACCGTCTGGATGAGGG
CTCAGATGTGGAATCAGAACCCGACCTCCCCCTGAAGCGCAAGCAGCGCCGCAGTCGGACCACGTTCACA
GCCGAGCAGCTGGAGGAGCTAGAGAAGGCCTTTGAGAGGACCCACTACCCGGACATCTACACCCGGGAGG
AGCTGGCACAGAGGACCAAGCTCACGGAGGCACGCGTCCAGGTCTGGTTCAGTAACCGGCGTGCCCGCTG
GCGCAAGCAGGCAGGAGCTAACCAGCTGGCCGCCTTCAACCACCTTCTGCCGGGAGGTTTCCCACCCACC
GGCATGCCCACGCTGCCACCCTACCAGCTGCCGGACTCTACCTACCCCACCACCACCATCTCCCAAGATG
GGGGCAGCACAGTACACAGGCCCCAGCCCCTTCCGCCATCAACCATGCATCAGGGTGGGCTGGCTGCGGC
CGCTGCAGCAGCAGACACCAGCTCTGCCTACGGAGCCCGCCACAGCTTCTCCAGCTACTCTGACAGCTTC
ATGAACCCTGGGGCTCCCTCCAACCACATGAACCCTGTCAGCAATGGCCTGTCTCCTCAGGTCATGAGCA
TCCTTAGCAACCCGAGTGCCGTGCCTCCACAGCCCCAGGCCGACTTCTCCATCTCCCCGCTGCATGGAGG
CCTGGACTCGGCTTCCTCCATCTCAGCCAGCTGCAGCCAACGGGCCGACTCCATCAAGCCAGGAGACAGC
TTGCCCACGTCCCAGTCTTACTGCCCACCCACCTACAGCACCACTGGCTACAGTGTGGACCCTGTGGCTG
GCTACCAGTACAGCCAGTATGGCCAAACTGCTGTTGATTACCTGGCCAAAAACGTGAGCCTGTCCACACA
GCGCCGTATGAAGCTTGGGGAACACTCCGCTGTGCTGGGACTTCTTCCTGTGGAAACGGGACAAGCCTAC
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